FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Luppe, MJ
   Verro, AT
   Barbosa, AS
   Nogueira, ML
   Undurraga, EA
   da Silva, NS
AF Luppe, Marina Jolli
   Verro, Alice Tobal
   Barbosa, Alana S.
   Nogueira, Mauricio L.
   Undurraga, Eduardo A.
   da Silva, Natal S.
TI Yellow fever (YF) vaccination does not increase dengue severity: A
   retrospective study based on 11,448 dengue notifications in a YF and
   dengue endemic region
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Article
DE Yellow fever; Dengue; Dengue severity; Yellow fever vaccination;
   Neglected tropical diseases
ID ANTIBODY-DEPENDENT ENHANCEMENT; CLASSIFYING DENGUE; HEMORRHAGIC-FEVER;
   MOTHERS REPORTS; VIRUS; CLASSIFICATION; INFECTION; IMMUNOGENICITY;
   REGRESSION; ACCURACY
AB Background: We study the association between prior yellow fever immunization and clinical outcomes of dengue infections in individuals of varying sexes and ages. Serological interactions between dengue virus and other flaviviruses could drive antibody dependent enhancement, which is associated with disease severity in dengue infections. This effect may influence disease severity in individuals subsequently affected by related flaviviruses, such as dengue. We compare the severity of dengue episodes between patients vaccinated and non-vaccinated against yellow fever.
   Methods: We evaluated the severity of 11,448 lab-confirmed dengue cases reported in Sao Jose do Rio Preto, Brazil, in 7370 YF vaccinated patients compared to 4043 unvaccinated patients. We regressed dengue severity against YF vaccine status and a number of demographic, clinical, and laboratory variables as controls. We also evaluated the association between YF vaccination status and the clinical and laboratory symptoms of dengue patients.
   Results: We did not find any evidence of increased risk for severe dengue in patients vaccinated against YF (odds ratio = 1.00; 95% confidence interval = 0.87-1.14). Most of the variables analyzed did not have a statistically significant association with YF vaccination status.
   Conclusions: We found no evidence that YF vaccination in dengue-endemic areas increases the risk of severe dengue fever.
C1 [Luppe, Marina Jolli; Verro, Alice Tobal; Barbosa, Alana S.; da Silva, Natal S.] Uniao Fac Grandes Lagos, Fac Med, Rua Dr Eduardo Nielsem,960 Jardim Novo Aeroporto, BR-15030070 Sao Jose Do Rio Preto, SP, Brazil.
   [Verro, Alice Tobal; da Silva, Natal S.] Uniao Fac Grandes Lagos, Fac Med, Lab Modelagens Matemat & Estat Med, Rua Dr Eduardo Nielsem,960 Jardim Novo Aeroporto, BR-15030070 Sao Jose Do Rio Preto, SP, Brazil.
   [Nogueira, Mauricio L.; da Silva, Natal S.] Fac Med Sao Jose do Rio Preto, Lab Pesquisa Virol, Av Brigadeiro Faria Lima 5416, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
   [Undurraga, Eduardo A.] Pontificia Univ Catolica Chile, Escuela Gobierno, Vicuna Mackenna 4860, Santiago 4860, Region Metropol, Chile.
RP da Silva, NS (corresponding author), Uniao Fac Grandes Lagos, Fac Med, Lab Modelagens Matemat & Estat Med, Rua Dr Eduardo Nielsem,960 Jardim Novo Aeroporto, BR-15030070 Sao Jose Do Rio Preto, SP, Brazil.
EM natalss@gmail.com
RI Nogueira, Mauricio L/B-7599-2012; da Silva, Natal Santos/E-9579-2015
OI Nogueira, Mauricio L/0000-0003-1102-2419; da Silva, Natal
   Santos/0000-0002-0856-1748
FU Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2013/21719-3]; INCT-Dengue
   (CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX This work was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo[2013/21719-3] and INCT-Dengue (CNPq) to MLN. MLN is a CNPq
   Research Fellow.
CR ANDERSON JA, 1984, J R STAT SOC B, V46, P1
   Anderson KB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001311
   [Anonymous], 2013, Wkly Epidemiol Rec, V88, P269
   [Anonymous], 2009, DENG GUID DIAGN TREA
   [Anonymous], 2018, UPD YELL FEV VACC RE
   Bandyopadhyay S, 2006, TROP MED INT HEALTH, V11, P1238, DOI 10.1111/j.1365-3156.2006.01678.x
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Berens-Riha N, 2014, INTERNIST, V55, P246, DOI 10.1007/s00108-013-3365-x
   Casali Clarisse Guimarães, 2004, Rev. Soc. Bras. Med. Trop., V37, P296, DOI 10.1590/S0037-86822004000400002
   da Silva NS, 2018, TROP MED INT HEALTH, V23, P1282, DOI 10.1111/tmi.13155
   Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Farrar JJ, 2013, AM J TROP MED HYG, V89, P198, DOI 10.4269/ajtmh.13-0157
   GAREABALLAH ET, 1989, B WORLD HEALTH ORGAN, V67, P669
   Gómez Sergio Y, 2008, Rev. salud pública, V10, P796
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001
   Guzman MG, 2010, VIRUSES-BASEL, V2, P2649, DOI 10.3390/v2122649
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   HALSTEAD SB, 1980, AM J TROP MED HYG, V29, P638, DOI 10.4269/ajtmh.1980.29.638
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   Hamer DH, 2018, MMWR-MORBID MORTAL W, V67, P340, DOI 10.15585/mmwr.mm6711e1
   Herricks JR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005424
   Houghton-Triviño Natalia, 2008, Rev. salud pública, V10, P299
   Huhn GD, 2006, VACCINE, V24, P730, DOI 10.1016/j.vaccine.2005.08.077
   Lanata CF, 2012, VACCINE, V30, P5935, DOI 10.1016/j.vaccine.2012.07.043
   Langsten R, 1998, SOC SCI MED, V46, P1205, DOI 10.1016/S0277-9536(97)10049-1
   Lemeshow S, 2013, APPL LOGISTIC REGRES
   Lindsey NP, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw045
   Lindsey NP, 2008, VACCINE, V26, P6077, DOI 10.1016/j.vaccine.2008.09.009
   Lopez P, 2016, PEDIATR INFECT DIS J, V35, P1140, DOI 10.1097/INF.0000000000001250
   Luz PM, 2009, TROP MED INT HEALTH, V14, P237, DOI 10.1111/j.1365-3156.2008.02203.x
   Mallhi TH, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1141-3
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Miles M, 2013, VACCINE, V31, P1560, DOI 10.1016/j.vaccine.2012.10.089
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821
   Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9
   Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Petersen J, 2017, TRAVEL MED INFECT DI, V18, P24, DOI 10.1016/j.tmaid.2017.07.002
   Phuong CXT, 2004, AM J TROP MED HYG, V70, P172, DOI 10.4269/ajtmh.2004.70.172
   Saad LD, 2016, EPIDEMIOL SERV SAUDE, V25, P531, DOI [10.5123/s1679-49742016000300009, 10.5123/S1679-49742016000300009]
   Sariol CA, 2018, TRENDS MICROBIOL, V26, P186, DOI 10.1016/j.tim.2017.10.004
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503
   Abreu MNS, 2009, REV SAUDE PUBL, V43, P183, DOI 10.1590/s0034-89102009000100025
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Sirivichayakul C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001520
   Chaves TDS, 2018, TRAVEL MED INFECT DI, V23, P1, DOI 10.1016/j.tmaid.2018.05.001
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Tauil PL, 2010, REV SAUDE PUBL, V44, P555, DOI 10.1590/S0034-89102010005000014
   Martelli CMT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004042
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2
   Watts DM, 1999, LANCET, V354, P1431, DOI 10.1016/S0140-6736(99)04015-5
   Wilder-Smith A, 2019, LANCET, V393, P350, DOI 10.1016/S0140-6736(18)32560-1
   World Health Organization, 1997, DENG HAEM FEV DIAGN
NR 58
TC 3
Z9 3
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JUL-AUG
PY 2019
VL 30
BP 25
EP 31
DI 10.1016/j.tmaid.2019.05.002
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA IN6OF
UT WOS:000478799000006
PM 31075425
DA 2020-12-08
ER

PT J
AU Chiaravalloti-Neto, F
   da Silva, RA
   Zini, N
   da Silva, GCD
   da Silva, NS
   Parra, MCP
   Dibo, MR
   Estofolete, CF
   Favaro, EA
   Dutra, KR
   Mota, MTO
   Guimaraes, GF
   Terzian, ACB
   Blangiardo, M
   Nogueira, ML
AF Chiaravalloti-Neto, Francisco
   da Silva, Rafael Alves
   Zini, Nathalia
   Dutra da Silva, Gislaine Celestino
   da Silva, Natal Santos
   Pereira Parra, Maisa Carla
   Dibo, Margareth Regina
   Estofolete, Cassia Fernanda
   Favaro, Eliane Aparecida
   Dutra, Karina Rocha
   Oliveira Mota, Manlio Tasso
   Guimaraes, Georgia Freitas
   Bernardes Terzian, Ana Carolina
   Blangiardo, Marta
   Nogueira, Mauricio Lacerda
TI Seroprevalence for dengue virus in a hyperendemic area and associated
   socioeconomic and demographic factors using a cross-sectional design and
   a geostatistical approach, state of SAo Paulo, Brazil
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Dengue; Seroprevalence; Cross-sectional study; Geostatiscal analysis;
   Brazil
ID RISK-FACTORS; AEDES-AEGYPTI; INFECTION; TRANSMISSION; ANTIBODIES;
   DISPERSAL; EPIDEMIC; FEVER
AB BackgroundSAo Jose do Rio Preto is one of the cities of the state of SAo Paulo, Brazil, that is hyperendemic for dengue, with the presence of the four dengue serotypes.Objectives: to calculate dengue seroprevalence in a neighbourhood of SAo Jose do Rio Preto and identify if socioeconomic and demographic covariates are associated with dengue seropositivity.MethodsA cohort study to evaluate dengue seroprevalence and incidence and associated factors on people aged 10yearsor older, was assembled in Vila Toninho neighbourhood, SAo Jose do Rio Preto. The participant enrolment occurred from October 2015 to March 2016 (the first wave of the cohort study), when blood samples were collected for serological test (ELISA IgG anti-DENV) and questionnaires were administrated on socio-demographic variables. We evaluated the data collected in this first wave using a cross-sectional design. We considered seropositive the participants that were positive in the serological test (seronegative otherwise). We modelled the seroprevalence with a logistic regression in a geostatistical approach. The Bayesian inference was made using integrated nested Laplace approximations (INLA) coupled with the Stochastic Partial Differential Equation method (SPDE).ResultsWe found 986 seropositive individuals for DENV in 1322 individuals surveyed in the study area in the first wave of the cohort study, corresponding to a seroprevalence of 74.6% (95%CI: 72.2-76.9). Between the population that said never had dengue fever, 68.4% (566/828) were dengue seropositive. Older people, non-white and living in a house (instead of in an apartment), were positively associated with dengue seropositivity. We adjusted for the other socioeconomic and demographic covariates, and accounted for residual spatial dependence between observations, which was found to present up to 800m.ConclusionsOnly one in four people aged 10years or older did not have contact with any of the serotypes of dengue virus in Vila Toninho neighbourhood in SAo Jose do Rio Preto. Age, race and type of house were associated with the occurrence of the disease. The use of INLA in a geostatistical approach in a Bayesian context allowed us to take into account the spatial dependence between the observations and identify the associated covariates to dengue seroprevalence.
C1 [Chiaravalloti-Neto, Francisco] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Ave Doutor Arnaldo 715, BR-01246904 Sao Paulo, SP, Brazil.
   [da Silva, Rafael Alves; Zini, Nathalia; Dutra da Silva, Gislaine Celestino; Pereira Parra, Maisa Carla; Estofolete, Cassia Fernanda; Favaro, Eliane Aparecida; Dutra, Karina Rocha; Oliveira Mota, Manlio Tasso; Guimaraes, Georgia Freitas; Bernardes Terzian, Ana Carolina; Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto FAMERP, Dept Doencas Dermatol Infecciosas & Parasitarias, Lab Pesquisas Virol, Ave Brigadeiro Faria Lima 5416, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
   [da Silva, Natal Santos] Uniao Fac Grandes Lagos, Fac Med, Lab Modelagens Matemat & Estat Med, Rua Doutor Eduardo Nielsen 960, BR-15030070 Sao Jose Do Rio Preto, SP, Brazil.
   [Dibo, Margareth Regina] Superintendencia Controle Endemias Estado Sao Paul, Lab Entomol, Rua Cardeal Arcoverde 2878, BR-05408003 Sao Paulo, SP, Brazil.
   [Blangiardo, Marta] Imperial Coll, MRC PHE Ctr Environm & Hlth, Dept Epidemiol & Biostat, St Marys Campus,Norfolk Pl, London W2 1PG, England.
RP Chiaravalloti-Neto, F (corresponding author), Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Ave Doutor Arnaldo 715, BR-01246904 Sao Paulo, SP, Brazil.
EM franciscochiara@usp.br
RI Neto, Francisco Chiaravalloti/F-8006-2012; da Silva, Natal
   Santos/E-9579-2015; Estofolete, Cassia/N-6673-2019; Nogueira, Mauricio
   L/B-7599-2012
OI Neto, Francisco Chiaravalloti/0000-0003-2686-8740; da Silva, Natal
   Santos/0000-0002-0856-1748; Estofolete, Cassia/0000-0001-7324-1591;
   Nogueira, Mauricio L/0000-0003-1102-2419
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2013/21719-3, 2016/15012-1, 2015/12295-0,
   2017/09671-6]; National Institute of Science and Technology in Dengue
   (INCT em Dengue); Coordination for the Improvement of Higher Education
   Personnel (CAPES)CAPES
FX This study was supported by the Sao Paulo Research Foundation (FAPESP)
   with grant numbers 2013/21719-3 and 2016/15012-1 for MLN, 2015/12295-0
   for ACBT and 2017/09671-6 for FCN. It is also supported by the National
   Institute of Science and Technology in Dengue (INCT em Dengue). RAS was
   supported by the Coordination for the Improvement of Higher Education
   Personnel (CAPES) with grant. MLN and FCN are CNPq (National Council for
   Scientific and Technological Development) Research Fellows. The funding
   agencies did not play any role in the design of the study and
   collection, analysis, and interpretation of data and in writing the
   manuscript.
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Amaya-Larios IY, 2014, AM J TROP MED HYG, V91, P1057, DOI 10.4269/ajtmh.14-0145
   [Anonymous], 2017, B EP MON CAS DENG FE
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blangiardo M, 2015, SPATIAL AND SPATIO-TEMPORAL BAYESIAN MODELS WITH R-INLA, P1, DOI 10.1002/9781118950203
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Carabali M, 2017, INT J INFECT DIS, V58, P27, DOI 10.1016/j.ijid.2017.02.016
   Castanha PMS, 2017, EPIDEMIOL INFECT, V145, P2971, DOI [10.1017/S095026881700214X, 10.1017/s095026881700214x]
   de Lima VLC, 2007, CAD SAUDE PUBLICA, V23, P669, DOI 10.1590/S0102-311X2007000300025
   Chiaravalloti Neto Francisco, 1997, Revista da Sociedade Brasileira de Medicina Tropical, V30, P279, DOI 10.1590/S0037-86821997000400002
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Cressie N., 1993, STAT SPATIAL DATA
   da Costa AIP, 1998, REV SAUDE PUBL, V32, P232, DOI 10.1590/S0034-89101998000300005
   da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P485, DOI 10.4269/ajtmh.2008.79.485
   Dhar-Chowdhury P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005475
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Farinelli EC, 2018, ACTA TROP, V180, P47, DOI 10.1016/j.actatropica.2018.01.005
   Favaro EA, AEDES AEGYPTI ENTOMO, DOI [10.1590/S0034-8910.2013047004506, DOI 10.1590/S0034-8910.2013047004506]
   Figueiredo Luiz Tadeu Moraes, 1995, Boletin de la Oficina Sanitaria Panamericana, V118, P499
   Forattini OP, 2002, CULICIDOLOGIA MED ID, V2
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Honorio NA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000545
   Imai N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003719
   Kumar A, 2015, J INFECT PUBLIC HEAL, V8, P583, DOI 10.1016/j.jiph.2015.05.013
   Liebman KA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001472
   Lima V L, 1999, Rev Saude Publica, V33, P566
   Pessanha JEM, 2010, REV PANAM SALUD PUBL, V27, P252, DOI 10.1590/S1020-49892010000400003
   Martin AS, 2015, INT PSYCHOGERIATR, V27, P601, DOI [10.1017/S104161021400221X, 10.1155/2014/703875]
   Mondini A, 2008, SCI TOTAL ENVIRON, V393, P241, DOI 10.1016/j.scitotenv.2008.01.010
   Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448
   Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   NOGUEIRA RMR, 1990, MEM I OSWALDO CRUZ, V85, P253, DOI 10.1590/S0074-02761990000200022
   Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007
   Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53
   Pereira Y, 2015, REV CHIL INFECTOL, V32, P618, DOI 10.4067/S0716-10182015000700002
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
   Chiavegatto ADP, 2013, CAD SAUDE PUBLICA, V29, P1572, DOI [10.1590/0102-311X00139012, 10.1590/S0102-311X2013001200010]
   Prayitno A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005621
   R Core Team, 2017, R LANG ENV STAT COMP
   REITER P, 1995, AM J TROP MED HYG, V52, P177, DOI 10.4269/ajtmh.1995.52.177
   Rocco IM, 2012, REV INST MED TROP SP, V54, P49, DOI 10.1590/S0036-46652012000100009
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935
   Rubin DB, 1987, MULTIPLE IMPUTATION
   Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x
   Santos Cecília Luiza S., 2004, Rev. Inst. Med. trop. S. Paulo, V46, P145, DOI 10.1590/S0036-46652004000300005
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245, DOI 10.1590/S0074-02761986000200019
   Simpson D, 2017, STAT SCI, V32, P1, DOI 10.1214/16-STS576
   Siqueira JB, 2004, AM J TROP MED HYG, V71, P646, DOI 10.4269/ajtmh.2004.71.646
   Siqueira JB, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-361
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Teixeira MG, 2012, TROP MED INT HEALTH, V17, P1391, DOI 10.1111/j.1365-3156.2012.03086.x
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   Teurlai M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004211
   van Buuren S, 2011, J STAT SOFTW, V45, P1
   Vasconcelos P F, 1999, Rev Soc Bras Med Trop, V32, P171
   Vasconcelos Pedro Fernando Da Costa, 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P141, DOI 10.1590/S0036-46651993000200005
   Vasconcelos PFC, 1998, REV SAUDE PUBL, V32, P447, DOI 10.1590/S0034-89101998000500007
   Velasco-Salas ZI, 2014, AM J TROP MED HYG, V91, P1039, DOI 10.4269/ajtmh.14-0127
   Vicenti- Gonzalez MF, 2017, PLOS NEGLECT TROP D, V11, P1
   Vongpunsawad S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180560
   Vos T, 2016, LANCET, V388, P1545, DOI 10.1016/S0140-6736(16)31678-6
   Weppelmann TA, 2017, AM J TROP MED HYG, V96, P135, DOI 10.4269/ajtmh.16-0422
   WHO, 2016, DENG VACC WHO POS PA
   Wijayanti SPM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004964
   Yung CF, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1662-4
   Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x
NR 71
TC 3
Z9 3
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD MAY 20
PY 2019
VL 19
AR 441
DI 10.1186/s12879-019-4074-4
PG 14
WC Infectious Diseases
SC Infectious Diseases
GA HY8SM
UT WOS:000468410700005
PM 31109295
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Tolentino, FM
   Bueno, MFC
   Franscisco, GR
   Barcelos, DDD
   Lobo, SM
   Tomaz, FMMB
   da Silva, NS
   de Andrade, LN
   Casella, T
   Darini, ALD
   Polotto, M
   Garcia, DD
   Nogueira, MCL
AF Tolentino, Fernanda Modesto
   Campagnari Bueno, Maria Fernanda
   Franscisco, Gabriela Rodrigues
   de Paula Barcelos, Diego Diniz
   Lobo, Suzana Margareth
   Moreira Batista Tomaz, Francieli Maira
   da Silva, Natal Santos
   de Andrade, Leonardo Neves
   Casella, Tiago
   da Costa Darini, Ana Lucia
   Polotto, Milena
   Garcia, Doroti de Oliveira
   Lelles Nogueira, Mara Correa
TI Endemicity of the High-Risk Clone Klebsiella pneumoniae ST340
   Coproducing QnrB, CTX-M-15, and KPC-2 in a Brazilian Hospital
SO MICROBIAL DRUG RESISTANCE
LA English
DT Article
DE Klebsiella pneumoniae; KPC; multiresistance
ID SPECTRUM-BETA-LACTAMASE; QUINOLONE RESISTANCE DETERMINANTS;
   AMINOGLYCOSIDE-MODIFYING ENZYMES; INTENSIVE-CARE-UNIT; ESCHERICHIA-COLI;
   CARBAPENEM-RESISTANT; HIGH PREVALENCE; COMPLEX 258; MOLECULAR
   CHARACTERIZATION; ANTIMICROBIAL RESISTANCE
AB The dissemination of multiresistant Klebsiella pneumoniae carbapenemase (KPC)-2-producing Klebsiella pneumoniae isolates belonging to international high-risk clones poses a major health care threat. In this study, 48 nonduplicated, carbapenem-resistant K. pneumoniae isolated from 2011 to 2014 in a tertiary hospital were investigated. The bla(KPC-2) gene was the only determinant for carbapenem resistance. The bla(CTX-M-15) gene was the main determinant for the production of extended-spectrum beta-lactamase (ESBL), whereas aph(3 ')-Ia and qnrB were the most common genes associated with resistance to aminoglycosides and quinolones, respectively. Nine different sequence types (STs) were identified. The most common was ST340. Molecular typing by enterobacterial repetitive intergenic consensus-PCR placed 48 strains among 10 different clusters. In the studied hospital, the high-risk clone of KPC-2-producing K. pneumoniae ST340, harboring genes that codify aminoglycoside modifying enzymes, QnrB and CTX-M-15 plus CTXM-2-type ESBLs, is disseminated and acts as a major agent of infections in critically ill patients.
C1 [Tolentino, Fernanda Modesto; Polotto, Milena] Adolfo Lutz Inst, Sao Jose Do Rio Preto, Brazil.
   [Tolentino, Fernanda Modesto] Univ Estadual Paulista, Sao Jose Do Rio Preto, Brazil.
   [Tolentino, Fernanda Modesto; de Paula Barcelos, Diego Diniz; Lobo, Suzana Margareth; Moreira Batista Tomaz, Francieli Maira; da Silva, Natal Santos; Casella, Tiago; Polotto, Milena; Lelles Nogueira, Mara Correa] Fac Med Sao Jose Do Rio Preto, Dept Doencas Dermatol Infecciosas & Parasitarias, Ctr Invest Microrganismos, Sao Jose Do Rio Preto, Brazil.
   [Campagnari Bueno, Maria Fernanda; Franscisco, Gabriela Rodrigues; Garcia, Doroti de Oliveira] Adolfo Lutz Inst, Ctr Bacteriol, Sao Paulo, Brazil.
   [da Silva, Natal Santos] Uniao Fac Grandes Lagos, Lab Modelagens Matemat & Estat Med, Sao Jose Do Rio Preto, SP, Brazil.
   [de Andrade, Leonardo Neves; da Costa Darini, Ana Lucia] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Anal Clin Toxicol & Bromatol, Ribeirao Preto, Brazil.
   [Casella, Tiago] Hosp Base, Lab Cent, Setor Microbiol Clin, Sao Jose Do Rio Preto, Brazil.
RP Nogueira, MCL (corresponding author), Fac Med Sao Jose Do Rio Preto, Ctr Invest Microrganismos, Bloco U6,Ave Brigadeiro Faria Lima 5416, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
EM ml.nogueira@famerp.br
RI da Silva, Natal Santos/E-9579-2015; Casella, Tiago/D-3600-2012;
   Tolentino, Fernanda Modesto/U-7657-2017
OI da Silva, Natal Santos/0000-0002-0856-1748; Casella,
   Tiago/0000-0002-1596-2734; Darini, Ana Lucia Costa/0000-0001-5433-926X;
   Tolentino, Fernanda Modesto/0000-0002-2172-6594
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2014/17184-00]; Coordination for the
   Improvement of the Higher Education Personnel (PNPD/CAPES 2015);
   FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2012/21709-5]
FX We thank Sao Paulo Research Foundation (FAPESP) for financial support
   (research grant number #2014/17184-00). During the course of this work,
   L.N.d.A. was supported by a postdoctoral fellowship from Coordination
   for the Improvement of the Higher Education Personnel (PNPD/CAPES 2015).
   D.d.O.G. was a research fellow of FAPESP (grant #2012/21709-5). We also
   thank the team of curators of the Institut Pasteur MLST system (Paris,
   France) for importing novel alleles, profiles, and/or isolates at
   http://bigsdb.web.pasteur.fr
CR Adler A, 2016, J ANTIMICROB CHEMOTH, V71, P2143, DOI 10.1093/jac/dkw106
   Akers KS, 2010, J CLIN MICROBIOL, V48, P1132, DOI 10.1128/JCM.02006-09
   Almaghrabi R, 2014, ANTIMICROB AGENTS CH, V58, P4443, DOI 10.1128/AAC.00099-14
   Andrade LN, 2018, DIAGN MICR INFEC DIS, V91, P164, DOI 10.1016/j.diagmicrobio.2018.01.007
   Andrade LN, 2014, J CLIN MICROBIOL, V52, P2530, DOI 10.1128/JCM.00088-14
   Andrade LN, 2011, ANTIMICROB AGENTS CH, V55, P3579, DOI 10.1128/AAC.01783-10
   Boerlin Patrick, 2008, Animal Health Research Reviews, V9, P115, DOI 10.1017/S146625230800159X
   Bremmer DN, 2014, ANTIMICROB AGENTS CH, V58, P7597, DOI 10.1128/AAC.03831-14
   Bueno MFC, 2013, ANTIMICROB AGENTS CH, V57, P2397, DOI 10.1128/AAC.02108-12
   Cao XL, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/1476-0711-13-16
   Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018
   Cartelle M, 2004, J CLIN MICROBIOL, V42, P4242, DOI 10.1128/JCM.42.9.4242-4249.2004
   Casella T, 2018, J GLOB ANTIMICROB RE, V13, P35, DOI 10.1016/j.jgar.2018.02.011
   Castanheira M, 2012, ANTIMICROB AGENTS CH, V56, P1668, DOI 10.1128/AAC.05942-11
   Cattoir V, 2007, J ANTIMICROB CHEMOTH, V60, P394, DOI 10.1093/jac/dkm204
   Chen L, 2014, TRENDS MICROBIOL, V22, P686, DOI 10.1016/j.tim.2014.09.003
   Chiu SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069428
   Chmelnitsky I, 2009, J ANTIMICROB CHEMOTH, V64, P718, DOI 10.1093/jac/dkp272
   Climaco EC, 2010, DIAGN MICR INFEC DIS, V68, P186, DOI 10.1016/j.diagmicrobio.2010.05.013
   Curiao T, 2010, J ANTIMICROB CHEMOTH, V65, P1608, DOI 10.1093/jac/dkq174
   De Rosa FG, 2015, FUTURE MICROBIOL, V10, P285, DOI [10.2217/fmb.14.121, 10.2217/FMB.14.121]
   Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005
   Doyle D, 2012, J CLIN MICROBIOL, V50, P3877, DOI 10.1128/JCM.02117-12
   Edelstein M, 2003, ANTIMICROB AGENTS CH, V47, P3724, DOI 10.1128/AAC.47.12.3724-3732.2003
   Falcone M, 2016, CLIN MICROBIOL INFEC, V22, P444, DOI 10.1016/j.cmi.2016.01.016
   Filippa N, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-18
   Garcia DD, 2008, ANTIMICROB AGENTS CH, V52, P1790, DOI 10.1128/AAC.01440-07
   Gonzalez-Padilla M, 2015, J ANTIMICROB CHEMOTH, V70, P905, DOI 10.1093/jac/dku432
   Haldorsen BC, 2014, DIAGN MICR INFEC DIS, V78, P66, DOI 10.1016/j.diagmicrobio.2013.10.001
   Hansen LH, 2007, J ANTIMICROB CHEMOTH, V60, P145, DOI 10.1093/jac/dkm167
   Hara Takafumi, 2015, Jpn J Antibiot, V68, P75
   Jaskulski MR, 2013, INT J ANTIMICROB AG, V42, P76, DOI 10.1016/j.ijantimicag.2013.03.009
   Jiao Y, 2015, PATHOG GLOB HEALTH, V109, P68, DOI 10.1179/2047773215Y.0000000004
   Karfunkel D, 2013, EUR J CLIN MICROBIOL, V32, P513, DOI 10.1007/s10096-012-1765-9
   Kim ES, 2009, DIAGN MICR INFEC DIS, V65, P335, DOI 10.1016/j.diagmicrobio.2009.07.006
   Kontopidou F, 2014, CLIN MICROBIOL INFEC, V20, pO117, DOI 10.1111/1469-0691.12341
   Lahlaoui H, 2015, PEDIATR RES, V77, P107, DOI 10.1038/pr.2014.153
   Le Jennifer, 2011, J Clin Med Res, V3, P106, DOI 10.4021/jocmr551w
   Lee CR, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00895
   Lofmark S, 2015, DRUG RESIST UPDATE, V20, P29, DOI 10.1016/j.drup.2015.05.001
   Ma JY, 2009, ANTIMICROB AGENTS CH, V53, P519, DOI 10.1128/AAC.00886-08
   Martinez-Martinez L, 2008, EXPERT REV ANTI-INFE, V6, P685, DOI 10.1586/14787210.6.5.685
   Martins WMBS, 2015, DIAGN MICR INFEC DIS, V83, P375, DOI 10.1016/j.diagmicrobio.2015.09.003
   Sampaio JLM, 2016, BRAZ J MICROBIOL, V47, P31, DOI 10.1016/j.bjm.2016.10.002
   Minarini LAR, 2008, J ANTIMICROB CHEMOTH, V62, P474, DOI 10.1093/jac/dkn237
   Minarini LAR, 2012, BRAZ J MICROBIOL, V43, P1309, DOI [10.1590/S1517-83822012000400010, 10.1590/S1517-838220120004000010]
   Miro E, 2013, MICROB DRUG RESIST, V19, P94, DOI 10.1089/mdr.2012.0125
   Morrill HJ, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv050
   Muzaheed, 2008, J ANTIMICROB CHEMOTH, V61, P1393, DOI 10.1093/jac/dkn109
   Nicoletti AG, 2012, ANTIMICROB AGENTS CH, V56, P4563, DOI 10.1128/AAC.00219-12
   Nigo M, 2013, ANTIMICROB AGENTS CH, V57, P5743, DOI 10.1128/AAC.00827-13
   Oteo J, 2013, J ANTIMICROB CHEMOTH, V68, P317, DOI 10.1093/jac/dks383
   Papadimitriou-Olivgeris M, 2013, DIAGN MICR INFEC DIS, V77, P169, DOI 10.1016/j.diagmicrobio.2013.06.007
   Pecor ND, 2015, MBIO, V6, DOI 10.1128/mBio.01030-15
   Peirano G, 2014, J CLIN MICROBIOL, V52, P1575, DOI 10.1128/JCM.00162-14
   Peirano G, 2010, ANTIMICROB AGENTS CH, V54, P1327, DOI 10.1128/AAC.01338-09
   Ramos PIP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-54
   Perez F, 2013, ANTIMICROB AGENTS CH, V57, P4602, DOI 10.1128/AAC.00725-13
   Pitout JDD, 2015, ANTIMICROB AGENTS CH, V59, P5873, DOI 10.1128/AAC.01019-15
   Ramirez MS, 2010, DRUG RESIST UPDATE, V13, P151, DOI 10.1016/j.drup.2010.08.003
   Ribeiro VB, 2013, J MED MICROBIOL, V62, P1721, DOI 10.1099/jmm.0.062141-0
   Cruz GR, 2013, MEM I OSWALDO CRUZ, V108, P924, DOI 10.1590/0074-0276130084
   Seki LM, 2013, BRAZ J INFECT DIS, V17, P640, DOI 10.1016/j.bjid.2013.03.012
   Sennati S, 2012, ANTIMICROB AGENTS CH, V56, P6003, DOI 10.1128/AAC.00745-12
   Sharma R, 2017, INT J ANTIMICROB AG, V49, P224, DOI 10.1016/j.ijantimicag.2016.10.025
   Strand Linda, 2014, BMC Res Notes, V7, P376, DOI 10.1186/1756-0500-7-376
   Tollentino FM, 2011, MICROB DRUG RESIST, V17, P7, DOI 10.1089/mdr.2010.0055
   Vaziri F, 2011, CLINICS, V66, P1519, DOI 10.1590/S1807-59322011000900002
   Villa L, 2014, ANTIMICROB AGENTS CH, V58, P1707, DOI 10.1128/AAC.01803-13
   Wang MH, 2009, ANTIMICROB AGENTS CH, V53, P1892, DOI 10.1128/AAC.01400-08
   Won SY, 2011, CLIN INFECT DIS, V53, P532, DOI 10.1093/cid/cir482
   Wong MHY, 2013, ANTIMICROB AGENTS CH, V57, P658, DOI 10.1128/AAC.01144-12
   Zagorianou A, 2012, EUROSURVEILLANCE, V17, P12
   Zhao JJ, 2010, ANTIMICROB AGENTS CH, V54, P4219, DOI 10.1128/AAC.00139-10
NR 74
TC 4
Z9 4
U1 0
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-6294
EI 1931-8448
J9 MICROB DRUG RESIST
JI Microb. Drug Resist.
PD MAY 1
PY 2019
VL 25
IS 4
BP 528
EP 537
DI 10.1089/mdr.2018.0006
EA DEC 2018
PG 10
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA HX9QD
UT WOS:000452993400001
PM 30543470
DA 2020-12-08
ER

PT J
AU da Silva, NS
   Undurraga, EA
   Verro, AT
   Nogueira, ML
AF da Silva, Natal Santos
   Undurraga, Eduardo A.
   Verro, Alice Tobal
   Nogueira, Mauricio Lacerda
TI Comparison between the traditional (1997) and revised (2009) WHO
   classifications of dengue disease: a retrospective study of 30 670
   patients
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article
DE dengue; dengue classification; dengue diagnosis; World Health
   Organization; clinical guidelines; neglected tropical diseases
ID TIME
AB Objective To compare WHO's traditional (1997) and revised (2009) guidelines for dengue classification, using a large sample of patients of all ages with varying clinical conditions from a dengue-endemic area in Brazil.
   Methods We compared 30 670 laboratory-confirmed dengue cases (1998-2012) using both WHO's dengue classification guidelines. Stereotype ordinal logistic regressions were used to analyse the association between patients' demographics and signs and symptoms related to dengue infection severity, as defined in the 1997 and 2009 guidelines. We then compared the degree of agreement in dengue classification of both guidelines.
   Results Dengue signs and symptoms in patients were poorly correlated to disease severity as defined by both guidelines (Cramer's V test <0.2). Hypotensive shock was the exception for both classifications, presenting dependence (Z = 56.42; P < 0.001, and Z = 55.24; P < 0.001) and high agreement (Cramers's V = 1; P < 0.001, and Cramers's V = 0.97; P < 0.001) for WHO 1997 and 2009, respectively. Last, we also found substantial agreement in disease classification between both guidelines (Kendall tau-b = 0.79; P < 0.001), although 2009 guidelines were more sensitive in the detection of severe cases.
   Conclusions We hope our results will inform the debate about dengue classification guidelines, particularly concerning clinical value, study comparability, and ways in which future guidelines can support the clinical management of dengue. Our results suggest that caution should be taken when using WHO guidelines to assess dengue severity to improve clinical management of patients.
C1 [da Silva, Natal Santos; Verro, Alice Tobal] Uniao Fac Grandes Lagos, Sao Jose Do Rio Preto, SP, Brazil.
   [da Silva, Natal Santos; Verro, Alice Tobal] Uniao Fac Grandes Lagos, Lab Modelagens Matemat & Estat Med, Sao Jose Do Rio Preto, SP, Brazil.
   [da Silva, Natal Santos; Nogueira, Mauricio Lacerda] Fac Med, Lab Pesquisas Virol, Sao Jose Do Rio Preto, SP, Brazil.
   [Undurraga, Eduardo A.] Pontificia Univ Catolica Chile, Escuela Gobierno, Santiago, Region Metropol, Chile.
RP da Silva, NS (corresponding author), Uniao Fac Grandes Lagos, Fac Med, Lab Modelagens Matemat & Estat Med, Rua Dr Eduardo Nielsem,960 Jardim Novo Aeroporto, BR-15030070 Sao Jose Do Rio Preto, SP, Brazil.
EM natalss@gmail.com
RI Nogueira, Mauricio L/B-7599-2012; da Silva, Natal Santos/E-9579-2015;
   Undurraga, Eduardo/I-3739-2014
OI Nogueira, Mauricio L/0000-0003-1102-2419; da Silva, Natal
   Santos/0000-0002-0856-1748; Undurraga, Eduardo/0000-0002-4425-1253
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/21719-3]
FX This work was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [2013/21719-3] to MLN. MLN is a CNPq Research Fellow.
CR Altman D. G., 1990, PRACTICAL STAT MED R
   Anderson KB, 2014, J INFECT DIS, V209, P360, DOI 10.1093/infdis/jit436
   Andries AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004100
   [Anonymous], 2009, DENG GUID DIAGN TREA
   Bandyopadhyay S, 2006, TROP MED INT HEALTH, V11, P1238, DOI 10.1111/j.1365-3156.2006.01678.x
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bravo L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003027
   da Silva NS, 2018, ACTA TROP, V177, P25, DOI 10.1016/j.actatropica.2017.09.025
   Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5
   Figueiredo MAA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000699
   Flamand C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172267
   Furlan NB, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1947-7
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001
   Hadinegoro RS, 2012, PAEDIATR INT CHILD H, V32, P33, DOI 10.1179/2046904712Z.00000000052
   Halstead SB, 2006, REV PANAM SALUD PUBL, V20, P407, DOI 10.1590/S1020-49892006001100007
   Halstead SB, 2013, AM J TROP MED HYG, V88, P212, DOI 10.4269/ajtmh.12-0197
   Halstead SB, 2012, PAEDIATR INT CHILD H, V32, P5, DOI 10.1179/2046904712Z.00000000045
   Horstick O, 2014, AM J TROP MED HYG, V91, P621, DOI 10.4269/ajtmh.13-0676
   Liebman KA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001472
   Limkittikul K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003241
   Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397
   Pan American Health Organization (PAHO), DENG ANN CAS REP DEN
   Abreu MNS, 2009, REV SAUDE PUBL, V43, P183, DOI 10.1590/s0034-89102009000100025
   Snow GE, 2014, AM J TROP MED HYG, V91, P1203, DOI 10.4269/ajtmh.14-0132
   Srikiatkhachorn A, 2011, CLIN INFECT DIS, V53, P563, DOI 10.1093/cid/cir451
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Tukasan C, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2128-4
   Vuong Nguyen Lam, 2016, Trop Med Health, V44, P14, DOI 10.1186/s41182-016-0014-9
   World Health Organization, 1997, DENG GUID DIAGN TREA
   Zakaria Z, 2014, J INFECT DEV COUNTR, V8, P869, DOI 10.3855/jidc.4283
NR 31
TC 7
Z9 6
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD DEC
PY 2018
VL 23
IS 12
BP 1282
EP 1293
DI 10.1111/tmi.13155
PG 12
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HC5FV
UT WOS:000451829800001
PM 30282115
OA Bronze
DA 2020-12-08
ER

PT J
AU da Silva, NS
   Undurraga, EA
   Ferreira, ERD
   Estofolete, CF
   Nogueira, ML
AF da Silva, Natal Santos
   Undurraga, Eduardo A.
   da Silva Ferreira, Elis Regina
   Estofolete, Cassia Fernanda
   Nogueira, Mauricio Lacerda
TI Clinical, laboratory, and demographic determinants of hospitalization
   due to dengue in 7613 patients: A retrospective study based on
   hierarchical models
SO ACTA TROPICA
LA English
DT Article
DE Dengue; Risk; Hospitalization; Clinical; Laboratory; Demographic
ID HEMORRHAGIC-FEVER; ECONOMIC BURDEN; RISK-FACTORS; SYMPTOMS; ADULTS;
   PERSISTENCE; INFECTIONS; MANAGEMENT; ALGORITHM; ACCURACY
AB In Brazil, the incidence of hospitalization due to dengue, as an indicator of severity, has drastically increased since 1998. The objective of our study was to identify risk factors associated with subsequent hospitalization related to dengue. We analyzed 7613 dengue confirmed via serology (ELISA), non-structural protein 1, or polymerase chain reaction amplification. We used a hierarchical framework to generate a multivariate logistic regression based on a variety of risk variables. This was followed by multiple statistical analyses to assess hierarchical model accuracy, variance, goodness of fit, and whether or not this model reliably represented the population. The final model, which included age, sex, ethnicity, previous dengue infection, hemorrhagic manifestations, plasma leakage, and organ failure, showed that all measured parameters, with the exception of previous dengue, were statistically significant. The presence of organ failure was associated with the highest risk of subsequent dengue hospitalization (OR = 575; CI = 3.53-9.37). Therefore, plasma leakage and organ failure were the main indicators of hospitalization due to dengue, although other variables of minor importance should also be considered to refer dengue patients to hospital treatment, which may lead to a reduction in avoidable deaths as well as costs related to dengue.
C1 [da Silva, Natal Santos; da Silva Ferreira, Elis Regina] Uniao Fac Grandes Lagos, Fac Med, Rua Dr Eduardo Nielsem 960, BR-15030070 Sao Jose Do Rio Preto, SP, Brazil.
   [da Silva, Natal Santos] Uniao Fac Grandes Lagos, Fac Med, Lab Modelagens Matemat & Estat Med, Rua Dr Eduardo Nielsem 960, BR-15030070 Sao Jose Do Rio Preto, SP, Brazil.
   [da Silva, Natal Santos; Estofolete, Cassia Fernanda; Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto, Lab Pesquisa Virol, Brigadeiro Feria Lima Ave 5416, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
   [Undurraga, Eduardo A.] Pontificia Univ Catolica Chile, Escuela Gobierno, Santiago, Region Memopoli, Chile.
   [Undurraga, Eduardo A.] Pontificia Univ Catolica Chile, Escuela Gobiemo, Vicuna Mackenna 4860, Macul 7820436, Region Metropol, Chile.
RP da Silva, NS (corresponding author), Uniao Fac Grandes Lagos, Fac Med, Lab Modelagens Matemat & Estat Med, Rua Dr Eduardo Nielsem 960, BR-15030070 Sao Jose Do Rio Preto, SP, Brazil.
EM natalss@gmail.com; eundurra@uc.cl; ereginaferreira@yahoo.com.br;
   cassiafestofolete@gmail.com; mnogueira@famerp.br
RI Nogueira, Mauricio L/B-7599-2012; Estofolete, Cassia/N-6673-2019;
   Undurraga, Eduardo/I-3739-2014; da Silva, Natal Santos/E-9579-2015
OI Nogueira, Mauricio L/0000-0003-1102-2419; Estofolete,
   Cassia/0000-0001-7324-1591; Undurraga, Eduardo/0000-0002-4425-1253; da
   Silva, Natal Santos/0000-0002-0856-1748
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/21719-3]
FX This work was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [2013/21719-3] to MLN. MLN is a CNPq Research Fellow.
CR Diaz-Quijano FA, 2011, REV PANAM SALUD PUBL, V30, P248, DOI 10.1590/S1020-49892011000900009
   Beatty ME, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000890
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   Burnett Mark, 2013, J Spec Oper Med, V13, P64
   Tiga DC, 2016, AM J TROP MED HYG, V94, P1085, DOI 10.4269/ajtmh.15-0896
   Carrasco L R, 2014, PLOS NEGLECT TROP D, V8, pe2972, DOI DOI 10.1371/J0URNAL.PNTD.0002972
   Cavalcanti LP, 2011, EMERG INFECT DIS, V17, P132, DOI 10.3201/eid1701.100321
   Coelho GE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004705
   Dettogni RS, 2015, HUM IMMUNOL, V76, P717, DOI 10.1016/j.humimm.2015.09.026
   Egger JR, 2007, EMERG INFECT DIS, V13, P924, DOI 10.3201/eid1306.070008
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Figueiredo MAA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000699
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001
   Guzman Maria G., 2002, International Journal of Infectious Diseases, V6, P118, DOI 10.1016/S1201-9712(02)90072-X
   HALSTEAD SB, 1981, AM J EPIDEMIOL, V114, P632, DOI 10.1093/oxfordjournals.aje.a113235
   Halstead SB, 2006, REV PANAM SALUD PUBL, V20, P407, DOI 10.1590/S1020-49892006001100007
   Hammond SN, 2005, AM J TROP MED HYG, V73, P1063
   Lee IK, 2008, AM J TROP MED HYG, V79, P149, DOI 10.4269/ajtmh.2008.79.149
   Lee VJ, 2009, TROP MED INT HEALTH, V14, P1154, DOI 10.1111/j.1365-3156.2009.02337.x
   Leo YS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-498
   Lorono-Pino MA, 1999, AM J TROP MED HYG, V61, P725, DOI 10.4269/ajtmh.1999.61.725
   Lye DC, 2008, SINGAP MED J, V49, P476
   Mallhi TH, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1141-3
   Moraes GH, 2013, AM J TROP MED HYG, V88, P670, DOI 10.4269/ajtmh.11-0774
   Huy NT, 2013, CRIT CARE, V17, DOI 10.1186/cc13135
   Pang JX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155993
   Rocha C, 2009, AM J TROP MED HYG, V81, P287, DOI 10.4269/ajtmh.2009.81.287
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Shepard DS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003306
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Teixeira LDS, 2010, CAD SAUDE PUBLICA, V26, P625
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Tamibmaniam J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161696
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Thai KTD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001180
   Thanachartwet V, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1386-5
   Tristao-Sa R, 2012, REV SOC BRAS MED TRO, V45, P675, DOI 10.1590/S0037-86822012000600004
   Undurraga EA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002056
   Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224
   Wichmann O, 2007, J INFECT DIS, V195, P1089, DOI 10.1086/512680
   Woon YL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004575
NR 45
TC 4
Z9 4
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD JAN
PY 2018
VL 177
BP 25
EP 31
DI 10.1016/j.actatropica.2017.09.025
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA FN1VN
UT WOS:000415779400004
PM 28964768
DA 2020-12-08
ER

PT J
AU Colombo, TE
   Estofolete, CF
   Reis, AFN
   da Silva, NS
   Aguiar, ML
   Cabrera, EMS
   dos Santos, INP
   Costa, FR
   Cruz, LEAA
   Rombola, PL
   Terzian, ACB
   Nogueira, ML
AF Colombo, Tatiana Elias
   Estofolete, Cassia Fernanda
   Negri Reis, Andreia Francesli
   da Silva, Natal Santos
   Aguiar, Morgana Lima
   Sotello Cabrera, Eliana Marcia
   Penha dos Santos, Izalco Nuremberg
   Costa, Fabiana Rodrigues
   Arao Antonio Cruz, Lilian Elisa
   Rombola, Patricia Lopes
   Bernardes Terzian, Ana Carolina
   Nogueira, Mauricio Lacerda
TI Clinical, laboratory and virological data from suspected ZIKV patients
   in an endemic arbovirus area
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Zika; Dengue; Arboviruses
ID MEDIUM-SIZED CITY; DENGUE VIRUS; CHIKUNGUNYA-VIRUS; COINFECTION;
   INFECTION; STATE
AB Background: The emergence of Zika virus (ZIKV) presents new challenges to both clinicians and public health authorities. Overlapping clinical features between the diseases caused by ZIKV, dengue (DENV) and chi-kungunya (CHIKV) and the lack of validated serological assays for ZIKV make accurate diagnosis difficult. Brazilian authorities largely rely on clinical and epidemiological data for the epidemiological and clinical classifications of most ZIKV cases.
   Objective: : To report the laboratory and clinical profiles of patients diagnosed with Zika fever based only on clinical and epidemiological data.
   Study design: We analyzed 433 suspected cases of ZIKV identified by the attending physician based on proposed clinical criteria. The samples were also screened for ZIKV, DENV and CHIKV using PCR.
   Results: Of the 433 patients analyzed, 168 (38.8%) were laboratory-confirmed for arboviruses: 96 were positive for ZIKV, 67 were positive for DENV (56 for DENV-2, 9 for DENV-1, and 2 for DENV-4), four were positive for co-infection with ZIKV/DENV-2, and one was positive for CHIKV. The most common signs or symptoms in the patients with laboratory-confirmed ZIKV were rash (100%), arthralgia (77.1%), fever (74.0%), myalgia (74.0%) and non-purulent conjunctivitis (69.8%). In patients with laboratory-confirmed DENV infections, the most frequently observed symptoms were rash (100%), fever (79.1%), myalgia (74.6%), headache (73.1%) and arthralgia (70.1%). The measure of association between clinical manifestations and laboratory manifestations among patients with ZIKV and DENV detected a statistically significant difference only in abdominal pain (p = 0.04), leukopenia (p = 0.003), and thrombocytopenia (p = 0.01).
   Conclusion: Our data suggests that clinical and epidemiological criteria alone are not a good tool for ZIKV and DENV differentiation, and that laboratory diagnosis should be mandatory.
C1 [Colombo, Tatiana Elias; Estofolete, Cassia Fernanda; Sotello Cabrera, Eliana Marcia; Bernardes Terzian, Ana Carolina; Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto FAMERP, Sao Jose Do Rio Preto, SP, Brazil.
   [Colombo, Tatiana Elias; Aguiar, Morgana Lima] Univ Paulista UNIP, Sao Jose Do Rio Preto, SP, Brazil.
   [Negri Reis, Andreia Francesli; Penha dos Santos, Izalco Nuremberg; Costa, Fabiana Rodrigues; Arao Antonio Cruz, Lilian Elisa; Rombola, Patricia Lopes] Prefeitura Sao Jose do Rio Preto, Dept Vigilancia Saude, Sao Jose Do Rio Preto, SP, Brazil.
   [da Silva, Natal Santos] Uniao Fac Grandes Lagos, Fac Med, Lab Modelagens Matemat & Estat Med, Sao Jose Do Rio Preto, SP, Brazil.
RP Nogueira, ML (corresponding author), Infecciosas & Parasitarias FAMERP Sao Jose do Rio, Dept Doencas Dermatol, Sao Jose Do Rio Preto, SP, Brazil.
EM mnogueira@famerp.br
RI Nogueira, Mauricio L/B-7599-2012; Estofolete, Cassia/N-6673-2019; da
   Silva, Natal Santos/E-9579-2015
OI Nogueira, Mauricio L/0000-0003-1102-2419; Estofolete,
   Cassia/0000-0001-7324-1591; da Silva, Natal Santos/0000-0002-0856-1748;
   Reis, AlessanRSS/0000-0001-8486-7469
FU Sao Paulo State Research Foundation (FAPESP)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2013/21719-3, 2015/12295-0];
   FAPESP Zika Network
FX This work was supported by the Sao Paulo State Research Foundation
   (FAPESP) under Grant #2013/21719-3 to MLN and the 2015/12295-0
   fellowship to ACBT. The FAPESP Zika Network supported this work. MLN is
   a CNPq fellow.
CR Amancio FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129046
   [Anonymous], 1998, Wkly Epidemiol Rec, V73, P182
   [Anonymous], 2009, DENG GUID DIAGN TREA
   Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Arshad I., 2011, PROF MED J, V18, P7
   Back Anne Tuiskunen, 2013, Infect Ecol Epidemiol, V3, DOI 10.3402/iee.v3i0.19839
   Banerjee M., 2008, MJAF, V64, P4
   Bashir A. B., 2015, J INFECT DIS IMMUN, V7, P7
   Terzian ACB, 2011, VECTOR-BORNE ZOONOT, V11, P291, DOI 10.1089/vbz.2009.0200
   Perdigao ACB, 2016, MEM I OSWALDO CRUZ, V111, P588, DOI 10.1590/0074-02760160140
   Brasil J.P., 2016, NEW ENGL J MED, V375, P1
   Brasil. Ministerio da Saude, 2016, DENG DIAGN MAN CLIN
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica, 2009, GUIA VIG EP MIN SAUD
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Chacon R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140890
   Chammard TB, 2017, EMERG INFECT DIS, V23, P696, DOI 10.3201/eid2304.161967
   Codeco CT, 2009, MEM I OSWALDO CRUZ, V104, P614, DOI 10.1590/S0074-02762009000400014
   Colombo TE, 2016, ACTA TROP, V164, P84, DOI 10.1016/j.actatropica.2016.09.004
   Colombo TE, 2013, REV INST MED TROP SP, V55, P275, DOI 10.1590/S0036-46652013000400009
   Control ECfDPa, 2015, RAP RISK ASS ZIK VIR
   Mota MTD, 2016, BRAZ J MICROBIOL, V47, P38, DOI 10.1016/j.bjm.2016.10.008
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Favaro EA, 2013, REV SAUDE PUBL, V47, P588, DOI 10.1590/S0034-8910.2013047004506
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heukelbach J, 2016, INFECT DEV CTRIES, V2, P116
   Ho TS, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-75
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lemeshow S, 2013, APPL LOGISTIC REGRES
   Ministerio da Saude Nota informativa - SVS/MS, 2016, PROC SER AB VIG FEBR
   Ministry of Housing Urban Poverty Alleviation Government of India, 2015, PROT AT SAUD RESP OC, P1
   Mondini A, 2005, REV SAUDE PUBL, V39, P444, DOI [10.1590/S0034-89102005000300016, 10.1590/s0034-89102005000300016]
   Mondini A, 2007, J CLIN VIROL, V40, P84, DOI 10.1016/j.jcv.2007.06.007
   Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Pan American Health Organization/World Health Organization (PAHO), 2015, GUIA VIG ENF VIR ZIK
   Tukasan C, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2128-4
   Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002620
   WHO, 2009, DENG GUID DIAGN TREA, P160
   World Health Organization, 1997, DENG HAEM FEV DIAGN
NR 48
TC 18
Z9 18
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD NOV
PY 2017
VL 96
BP 20
EP 25
DI 10.1016/j.jcv.2017.09.002
PG 6
WC Virology
SC Virology
GA FN3UV
UT WOS:000415927400005
PM 28918127
DA 2020-12-08
ER

PT J
AU Tukasan, C
   Furlan, NB
   Estofolete, CF
   Nogueira, ML
   da Silva, NS
AF Tukasan, Caroline
   Furlan, Nathalia Barbosa
   Estofolete, Cassia Fernanda
   Nogueira, Mauricio Lacerda
   da Silva, Natal Santos
TI Evaluation of the importance of fever with respect to dengue prognosis
   according to the 2009 WHO classification: a retrospective study
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Dengue fever; Severe dengue; Dengue epidemiology; WHO 2009
   classification
ID DISEASE SEVERITY; VIRUS-INFECTION; ZIKA; CHIKUNGUNYA; ADULTS; BRAZIL
AB Background: The 2009 revised World Health Organization (WHO) guidelines for dengue describe fever as the core symptom. Accordingly, the diagnosis of non-febrile patients is complicated. The aim of this study was to evaluate the importance of fever in patients with dengue according to the 2009 revised WHO classification.
   Methods: In this study, we assessed 30,670 dengue cases using enzyme-linked immunosorbent assay, detection of the non-structural protein 1, or polymerase chain reaction for diagnostic confirmation. Fisher's exact test was used to evaluate associations between fever and related clinical manifestations. The Mann-Whitney U test was used to assess the association of dengue classification with fever and time to treatment. The effects of fever and time to treatment on the risk of progression were analyzed using an ordinal logistic regression to stereotype the model.
   Results: Disease classification was found to associate significantly with both fever and time to treatment (both P < 0.001). Non-febrile patients were nearly four-fold more likely to exhibit "dengue without warning signs" than "severe dengue" (odds ratio [OR] = 3.74; 95% confidence interval [CI]: 3.20-4.36). Patients who received treatment within 7 days were twice as likely to have " dengue without warning signs" as opposed to " severe dengue" when compared to those who waited >7 days (OR = 2.23; 95% CI: 1.78-2.80). However, this difference was negligible in the multivariate analysis (OR = 1.02; 95% CI: 0.98-1.07).
   Conclusions: Fever is a risk factor for disease progression in patients with dengue. However, non-febrile patients should not be neglected because this may delay treatment and could lead to more severe disease.
C1 [Tukasan, Caroline; Furlan, Nathalia Barbosa; da Silva, Natal Santos] Uniao Fac Grandes Lagos, Fac Med, Sao Paulo, Brazil.
   [Estofolete, Cassia Fernanda; Nogueira, Mauricio Lacerda; da Silva, Natal Santos] Fac Med Sao Jose do Rio Preto, Lab Pesquisas Virol, Sao Paulo, Brazil.
   [da Silva, Natal Santos] Uniao Fac Grandes Lagos, Fac Med, Lab Modelagens Matemat & Estat Med, Sao Paulo, Brazil.
RP da Silva, NS (corresponding author), Uniao Fac Grandes Lagos, Fac Med, Sao Paulo, Brazil.; Nogueira, ML; da Silva, NS (corresponding author), Fac Med Sao Jose do Rio Preto, Lab Pesquisas Virol, Sao Paulo, Brazil.; da Silva, NS (corresponding author), Uniao Fac Grandes Lagos, Fac Med, Lab Modelagens Matemat & Estat Med, Sao Paulo, Brazil.
EM mnogueira@famerp.br; natalss@gmail.com
RI da Silva, Natal Santos/E-9579-2015; Estofolete, Cassia/N-6673-2019;
   Nogueira, Mauricio L/B-7599-2012
OI da Silva, Natal Santos/0000-0002-0856-1748; Estofolete,
   Cassia/0000-0001-7324-1591; Nogueira, Mauricio L/0000-0003-1102-2419
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/21719-3]
FX This work was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [2013/21719-3] to MLN.
CR Amancio FF, 2015, BRAZIL PLOS ONE, V10
   [Anonymous], 2009, DENG GUID DIAGN TREA
   Barniol J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-106
   Cavalcanti LPD, 2014, MEM I OSWALDO CRUZ, V109, P93, DOI 10.1590/0074-0276140384
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Gautret P, 2016, TRAVEL MED INFECT DI, V14, P7, DOI 10.1016/j.tmaid.2015.12.004
   Heilman James M, 2014, Open Med, V8, pe105
   Ho TS, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-75
   Hoffmeister B, 2015, INFECTION, V43, P21, DOI 10.1007/s15010-014-0688-z
   Huang SY, 2015, AM J TROP MED HYG, V92, P75, DOI 10.4269/ajtmh.14-0343
   Louis VR, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-50
   Mayxay M, 2011, TROP MED INT HEALTH, V16, P127, DOI 10.1111/j.1365-3156.2010.02641.x
   Milligan GN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125476
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397
   Tuan NM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003638
   Schmid MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00647
   Singhi S, 2007, J PEDIAT-BRAZIL, V83, pS22, DOI 10.1590/S0021-75572007000300004
   Srikiatkhachorn A, 2011, CLIN INFECT DIS, V53, P563, DOI 10.1093/cid/cir451
   Suleman M, 2016, ASIAN PAC J TROP MED, V9, P371, DOI 10.1016/j.apjtm.2016.03.010
   Syenina A, 2015, ELIFE, V4, DOI 10.7554/eLife.05291
   Thanachartwet V, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1150-2
   Unnikrishnan Rahul, 2015, J Family Med Prim Care, V4, P369, DOI 10.4103/2249-4863.161323
NR 24
TC 6
Z9 6
U1 0
U2 7
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JAN 4
PY 2017
VL 17
AR 6
DI 10.1186/s12879-016-2128-4
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA EG5GZ
UT WOS:000391073200001
PM 28052760
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Canal, MR
   Ferreira, ERD
   Estofolete, CF
   Dias, AM
   Tukasan, C
   Bertoque, AC
   Muniz, VD
   Nogueira, ML
   da Silva, NS
AF Canal, Mayara Romero
   da Silva Ferreira, Elis Regina
   Estofolete, Cassia Fernanda
   Dias, Andreia Martiniano
   Tukasan, Caroline
   Bertoque, Ana Carolina
   Muniz, Vitor Dantas
   Nogueira, Mauricio Lacerda
   da Silva, Natal Santos
TI Spatiotemporal-based clusters as a method for dengue surveillance
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA English
DT Article
DE Geographic information systems; dengue; public health surveillance;
   communicable diseases; emerging; Brazil
AB Objectives. To develop and demonstrate the use of a new method for epidemiological surveillance of dengue.
   Methods. This was a retrospective cohort study using data from the Health Department of Sao Jose do Rio Preto (Sao Paulo, Brazil). The geographical coordinates were obtained using QGIS (TM) (Creative Commons Corporation, Mountain View, California, United States), based on patient addresses in the dengue notification system of the Government of Brazil. SaTScan (TM) (Martin Kulldorff, Boston, Massachusetts, United States) was then used to create a space-time scan analysis to find statistically significant clusters of dengue. These results were plotted and visualized using Google Earth (TM) mapping service (Google Incorporated, Mountain View, California, United States).
   Results. More clusters were detected when the maximum number of households per cluster was set to 10% (11 statistically significant clusters) rather than 50% (8 statistically significant clusters). The cluster radius varied from 0.18 - 2.04 km and the period of time varied from 6 days - 6 months. The infection rate was more than 0.5 cases/household.
   Conclusions. When using SaTScan for space-time analysis of dengue cases, the maximum number of households per cluster should be set to 10%. This methodology may be useful to optimizing dengue surveillance systems, especially in countries where resources are scarce and government programs have not had much success controlling the disease.
C1 [Canal, Mayara Romero; da Silva Ferreira, Elis Regina; Dias, Andreia Martiniano; Tukasan, Caroline; Bertoque, Ana Carolina; Muniz, Vitor Dantas] Uniao Fac Grandes Lagos, Fac Med, Sao Jose Do Rio Preto, SP, Brazil.
   [Estofolete, Cassia Fernanda; Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto, Lab Pesquisas Virol, Sao Paulo, Brazil.
   [da Silva, Natal Santos] Uniao Fac Grandes Lagos, Lab Modelagens Matemat & Estat Med, Sao Jose Do Rio Preto, SP, Brazil.
RP da Silva, NS (corresponding author), Uniao Fac Grandes Lagos, Lab Modelagens Matemat & Estat Med, Sao Jose Do Rio Preto, SP, Brazil.
EM natalss@gmail.com
RI da Silva, Natal Santos/E-9579-2015; Estofolete, Cassia/N-6673-2019;
   Nogueira, Mauricio L/B-7599-2012
OI da Silva, Natal Santos/0000-0002-0856-1748; Estofolete,
   Cassia/0000-0001-7324-1591; Nogueira, Mauricio L/0000-0003-1102-2419
FU Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [FAPESP-2013/21719-3]
FX This work was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP-2013/21719-3) to MLN, who is a CNPq Research Fellow.
CR [Anonymous], 2009, DENG GUID DIAGN TREA
   Baglini Virgínia, 2005, Cad. Saúde Pública, V21, P1142, DOI 10.1590/S0102-311X2005000400016
   Banu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089440
   Banu S, 2012, TROP MED INT HEALTH, V17, P1086, DOI 10.1111/j.1365-3156.2012.03038.x
   Carvalho Renata Marzzano de, 2014, Rev Assoc Med Bras (1992), V60, P565, DOI 10.1590/1806-9282.60.06.016
   da Silva NS, 2010, T ROY SOC TROP MED H, V104, P343, DOI 10.1016/j.trstmh.2009.12.010
   da Silva NS, 2014, AM J INFECT CONTROL, V42, P389, DOI 10.1016/j.ajic.2013.11.010
   Toan DTT, 2013, GLOBAL HEALTH ACTION, V6, P7, DOI 10.3402/gha.v6i0.18632
   Duczmal LH, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-29
   Estallo EL, 2014, ACTA TROP, V136, P129, DOI 10.1016/j.actatropica.2014.04.024
   Hino Paula, 2006, Rev. Latino-Am. Enfermagem, V14, P939, DOI 10.1590/S0104-11692006000600016
   Instituto Brasileiro de Geografia e Estatistica, 2015, PERF MUN RIO DE JAN
   KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809
   Li ZJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-132
   Lover AA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-658
   Scherrer LR, 2012, PLOS ONE, V7
   Sharma KD, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-341
   Tumioto GL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104394
   Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730
NR 19
TC 0
Z9 0
U1 0
U2 0
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PY 2017
VL 41
AR e162
DI 10.26633/RPSP.2017.162
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GP8CX
UT WOS:000441138600045
PM 31384275
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Furlan, NB
   Tukasan, C
   Estofolete, CF
   Nogueira, ML
   da Silva, NS
AF Furlan, Nathalia Barbosa
   Tukasan, Caroline
   Estofolete, Cassia Fernanda
   Nogueira, Mauricio Lacerda
   da Silva, Natal Santos
TI Low sensitivity of the tourniquet test for differential diagnosis of
   dengue: an analysis of 28,000 trials in patients
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Dengue; Tourniquet test; Diagnostic test for dengue
ID HEMORRHAGIC-FEVER; VIRUS; INFECTION; JAPAN; OUTBREAK; CHILDREN; UTILITY;
   ELISA
AB Background: The aim of this study was to evaluate the utility of the tourniquet test (TT) for dengue diagnosing. To our knowledge, no previous study with such a large sample, of this duration, with as many laboratory methods referenced, or relating the results of the TT to the 2009 WHO classification of severity has been conducted thus far.
   Methods: In this study, we analyzed the records of 119,589 suspected dengue cases in a Brazilian city, with 30,670 confirmed cases. The Cohen's Kappa test was applied to evaluate the degree of agreement between the tests, and the sensitivity and specificity was calculated for the TT.
   Results: Twenty-eight thousand six hundred thirty-five TT were performed. No association between the outcome of the TT and greater severity of infection, according to the 2009 guideline, was observed (P = 0.28); furthermore, relevant agreement with the final diagnosis (kappa = 0.01; 95 % CI = 0.00 to 0.02) or individually with the IgM enzyme-linked immunoassay was not observed (kappa = 0.05; 95 % CI = 0.04 to 0.06), and was even lower with PCR (kappa = 0.27; 95 % CI = 0.06 to 0.49). Most importance of the TT was shown in relation to specificity (88.9 %; 95 % CI = 0.88 to 0.89) and negative predictive value (70.3 %; CI 95 % = 0.70 to 0.71).
   Conclusions: TT was more effective in detecting cases that were truly negative than positive. These results suggest that the TT should not be used as diagnosis of dengue.
C1 [Furlan, Nathalia Barbosa; Tukasan, Caroline; Estofolete, Cassia Fernanda; da Silva, Natal Santos] Uniao Fac Grandes Lagos, Fac Med, Sao Jose Do Rio Preto, SP, Brazil.
   [Estofolete, Cassia Fernanda; Nogueira, Mauricio Lacerda; da Silva, Natal Santos] Fac Med Sao Jose do Rio Preto, Lab Pesquisas Virol, Sao Jose Do Rio Preto, SP, Brazil.
   [da Silva, Natal Santos] Uniao Fac Grandes Lagos, Lab Modelagens Matemat & Estat Med, Sao Jose Do Rio Preto, SP, Brazil.
   [da Silva, Natal Santos] Uniao Fac Grandes Lagos, Fac Med, Lab Modelagens Matemat & Estat Med, 960 Jardim Novo Aeroporto, BR-15030070 Sao Jose Do Rio Preto, SP, Brazil.
RP da Silva, NS (corresponding author), Uniao Fac Grandes Lagos, Fac Med, Sao Jose Do Rio Preto, SP, Brazil.; da Silva, NS (corresponding author), Fac Med Sao Jose do Rio Preto, Lab Pesquisas Virol, Sao Jose Do Rio Preto, SP, Brazil.; da Silva, NS (corresponding author), Uniao Fac Grandes Lagos, Lab Modelagens Matemat & Estat Med, Sao Jose Do Rio Preto, SP, Brazil.; da Silva, NS (corresponding author), Uniao Fac Grandes Lagos, Fac Med, Lab Modelagens Matemat & Estat Med, 960 Jardim Novo Aeroporto, BR-15030070 Sao Jose Do Rio Preto, SP, Brazil.
EM natalss@gmail.com
RI da Silva, Natal Santos/E-9579-2015; Estofolete, Cassia/N-6673-2019;
   Nogueira, Mauricio L/B-7599-2012
OI da Silva, Natal Santos/0000-0002-0856-1748; Estofolete,
   Cassia/0000-0001-7324-1591; Nogueira, Mauricio L/0000-0003-1102-2419
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/21719-3]
FX This work was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [2013/21719-3] to MLN.
CR Ahmed NH, 2014, J VECTOR DIS, V51, P194
   Anez G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/678645
   Antunes AC, 2013, REV SOC BRAS MED TRO, V46, P542, DOI 10.1590/0037-8682-0161-2013
   Arima Y, 2014, WEST PAC SURVEILL RE, V5, P27, DOI [10.5365/wpsar.2014.5.3.007, 10.5365/WPSAR.2014.5.3.007]
   Barros Lilian P. S., 2008, Rev. Bras. Hematol. Hemoter., V30, P363, DOI 10.1590/S1516-84842008000500007
   Terzian ACB, 2011, VECTOR-BORNE ZOONOT, V11, P291, DOI 10.1089/vbz.2009.0200
   Bessoff K, 2010, CLIN VACCINE IMMUNOL, V17, P949, DOI 10.1128/CVI.00041-10
   Burnett Mark, 2013, J Spec Oper Med, V13, P64
   Colombo TE, 2013, J CLIN VIROL, V58, P710, DOI 10.1016/j.jcv.2013.10.021
   Drumond BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059422
   Ferreira GLC, 2012, REV INST MED TROP SP, V54, pS5, DOI 10.1590/S0036-46652012000700003
   Figueiredo MAA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000699
   Gregory CJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001400
   Halsey ES, 2013, AM J TROP MED HYG, V89, P99, DOI 10.4269/ajtmh.13-0103
   HALSTEAD SB, 1989, REV INFECT DIS, V11, pS830
   HALSTEAD SB, 1981, AM J EPIDEMIOL, V114, P632, DOI 10.1093/oxfordjournals.aje.a113235
   Ho TS, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-75
   Kabra SK, 1999, T ROY SOC TROP MED H, V93, P294, DOI 10.1016/S0035-9203(99)90027-5
   Kalayanarooj S, 1997, J INFECT DIS, V176, P313, DOI 10.1086/514047
   Kittigul L, 2007, J CLIN VIROL, V39, P76, DOI 10.1016/j.jcv.2007.04.006
   Kojima G, 2015, EMERG INFECT DIS, V21, P182, DOI 10.3201/eid2101.141581
   Kutsuna S, 2015, EMERG INFECT DIS, V21, P517, DOI [10.3201/eid2103.141662, 10.3201/eid2103/141662]
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lorono-Pino MA, 1999, AM J TROP MED HYG, V61, P725, DOI 10.4269/ajtmh.1999.61.725
   Mayxay M, 2011, TROP MED INT HEALTH, V16, P127, DOI 10.1111/j.1365-3156.2010.02641.x
   Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905
   Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448
   Mustafa M S, 2015, Med J Armed Forces India, V71, P67, DOI 10.1016/j.mjafi.2014.09.011
   Norlijah O, 2006, Med J Malaysia, V61, P22
   Phuong CXT, 2002, TROP MED INT HEALTH, V7, P125, DOI 10.1046/j.1365-3156.2002.00841.x
   Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130
   Srichaikul T, 2000, BEST PRACT RES CL HA, V13, P261, DOI 10.1053/beha.2000.0073
   Srikiatkhachorn A, 2011, CLIN INFECT DIS, V53, P563, DOI 10.1093/cid/cir451
   Srikiatkhachorn A, 2010, CLIN INFECT DIS, V50, P1135, DOI 10.1086/651268
   Succo T, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.21.30240
   Teets FD, 2013, ORIGIN DENGUE VIRUS, V1-2, P2
   Thein TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081060
   Tristao-Sa R, 2012, REV SOC BRAS MED TRO, V45, P675, DOI 10.1590/S0037-86822012000600004
   Tumioto GL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104394
   Villabona-Arenas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063496
   Zhang H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/359308
NR 41
TC 4
Z9 4
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD NOV 3
PY 2016
VL 16
AR 627
DI 10.1186/s12879-016-1947-7
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA EA9NZ
UT WOS:000386972300005
PM 27809813
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU da Silva, NS
   Muniz, VD
   Estofolete, CF
   Furtado, GHC
   Rubio, FG
AF da Silva, Natal Santos
   Muniz, Vitor Dantas
   Estofolete, Cassia Fernanda
   Campos Furtado, Guilherme Henrique
   Rubio, Fernando Gongora
TI Identification of temporal clusters and risk factors of bacteremia by
   nosocomial vancomycin-resistant enterococci
SO AMERICAN JOURNAL OF INFECTION CONTROL
LA English
DT Article
DE Cohort study; Sepsis; Antibiotic; Resistance profile
ID EPIDEMIOLOGY; ACQUISITION; INFECTIONS; MORTALITY; OUTCOMES
AB Background: This study aimed to evaluate a different methodology for addressing the evolution of nosocomial bacteremia by vancomycin-resistant enterococci (VRE) in a hospital setting.
   Methods: In this retrospective cohort study, data were collected from the date of first registration up to December 2008 from the electronic medical records of patients with VRE bacteremia in a school hospital.
   Results: Thirty cases of VRE bacteremia and 274 cases of vancomycin-susceptible enterococci (VSE) bacteremia were identified. The average age of the patients was 56 years. The rates of Enterococcus faecium and Enterococcus faecalis in the hospital's intensive care unit (ICU) and wards showed no statistically significant differences. The risk of acquiring VRE bacteremia was at least 3-fold higher in the ICU than in the wards. The risk of death was 2.73-fold higher in patients with VRE bacteremia compared with those with VSE bacteremia. Only one temporal cluster statistically significant of VRE bacteremia was found in the study period.
   Conclusions: The identification of temporal clusters can be an important tool to optimize health actions and thereby reduce the burden of operating costs. Copyright (C) 2014 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
C1 [da Silva, Natal Santos] Med Coll Sao Jose do Rio Preto, Postgrad Dept, Sao Paulo, Brazil.
   [da Silva, Natal Santos] Union Coll Great Lakes, Coll Med, Dept Med Sci, Sao Paulo, Brazil.
   [Muniz, Vitor Dantas; Estofolete, Cassia Fernanda; Rubio, Fernando Gongora] Hosp Base, Dept Infect & Parasit Dis, Sao Paulo, Brazil.
   [Estofolete, Cassia Fernanda] Med Coll Sao Jose do Rio Preto, Virol Lab, Sao Paulo, Brazil.
   [Campos Furtado, Guilherme Henrique] Univ Fed Sao Paulo, Dept Infect Dis, Hosp Epidemiol Comm, Sao Paulo, Brazil.
RP da Silva, NS (corresponding author), Med Coll Sao Jose do Rio Preto, Postgrad Dept, 5416 Brigadeiro Faria Lima Ave, BR-15090000 Vila Sao Pedro, Sao Jose Do Rio, Brazil.
EM natalss@gmail.com
RI da Silva, Natal Santos/E-9579-2015; Estofolete, Cassia/N-6673-2019; da
   Silva, Natal Santos/Y-1913-2019
OI da Silva, Natal Santos/0000-0002-0856-1748; Estofolete,
   Cassia/0000-0001-7324-1591; da Silva, Natal Santos/0000-0002-0856-1748
CR Alvarez-Lerma F, 2002, ENFERM INFEC MICR CL, V20, P57, DOI 10.1016/S0213-005X(02)72742-0
   Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651
   Axon RN, 2004, INFECT CONT HOSP EP, V25, P436, DOI 10.1086/502419
   Beggs CB, 2006, AM J INFECT CONTROL, V34, P621, DOI 10.1016/j.ajic.2006.06.011
   Furtado GHC, 2006, AM J INFECT CONTROL, V34, P447, DOI 10.1016/j.ajic.2005.08.015
   Carmeli Y, 2002, ARCH INTERN MED, V162, P2223, DOI 10.1001/archinte.162.19.2223
   Cohen MJ, 2009, AM J INFECT CONTROL, V37, P111, DOI 10.1016/j.ajic.2008.04.260
   Dalla Costa L.M., 1998, BRAZ J INFECT DIS, V2, P160
   DiazGranados CA, 2005, CLIN INFECT DIS, V41, P327, DOI 10.1086/430909
   Fica A, 2007, REV CHIL INFECTOL, V24, P462, DOI [/S0716-10182007000600006, 10.4067/S0716-10182007000600006]
   Joels CS, 2003, AM SURGEON, V69, P514
   Oprea SF, 2004, J ANTIMICROB CHEMOTH, V53, P626, DOI 10.1093/jac/dkh138
   Reis A O, 2001, Braz J Infect Dis, V5, P243
   Sakka V, 2008, CLIN MICROBIOL INFEC, V14, P14, DOI 10.1111/j.1469-0691.2007.01840.x
   UTTLEY AHC, 1988, LANCET, V1, P57
   Winston LG, 2002, AM J INFECT CONTROL, V30, P400, DOI 10.1067/mic.2002.122647
NR 16
TC 12
Z9 12
U1 0
U2 4
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-6553
EI 1527-3296
J9 AM J INFECT CONTROL
JI Am. J. Infect. Control
PD APR
PY 2014
VL 42
IS 4
BP 389
EP 392
DI 10.1016/j.ajic.2013.11.010
PG 4
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA AD8OI
UT WOS:000333525100012
PM 24679566
DA 2020-12-08
ER

PT J
AU Orjuela-Sanchez, P
   Karunaweera, ND
   da Silva-Nunes, M
   da Silva, NS
   Scopel, KKG
   Goncalves, RM
   Amaratunga, C
   Sa, JM
   Socheat, D
   Fairhust, RM
   Gunawardena, S
   Thavakodirasah, T
   Galapaththy, GLN
   Abeysinghe, R
   Kawamoto, F
   Wirth, DF
   Ferreira, MU
AF Orjuela-Sanchez, Pamela
   Karunaweera, Nadira D.
   da Silva-Nunes, Monica
   da Silva, Natal S.
   Scopel, Kezia K. G.
   Goncalves, Raquel M.
   Amaratunga, Chanaki
   Sa, Juliana M.
   Socheat, Duong
   Fairhust, Rick M.
   Gunawardena, Sharmini
   Thavakodirasah, Thuraisamy
   Galapaththy, Gawrie L. N.
   Abeysinghe, Rabindra
   Kawamoto, Fumihiko
   Wirth, Dyann F.
   Ferreira, Marcelo U.
TI Single-nucleotide polymorphism, linkage disequilibrium and geographic
   structure in the malaria parasite Plasmodium vivax: prospects for
   genome-wide association studies
SO BMC GENETICS
LA English
DT Article
ID BRAZILIAN AMAZON REGION; CHLOROQUINE RESISTANCE; POPULATION-STRUCTURE;
   TRANSMISSION DYNAMICS; MOLECULAR MARKERS; NATURAL-SELECTION; ALLELIC
   DIVERSITY; GENETIC-STRUCTURE; HAPLOTYPE BLOCKS; RURAL AMAZONIA
AB Background: The ideal malaria parasite populations for initial mapping of genomic regions contributing to phenotypes such as drug resistance and virulence, through genome-wide association studies, are those with high genetic diversity, allowing for numerous informative markers, and rare meiotic recombination, allowing for strong linkage disequilibrium (LD) between markers and phenotype-determining loci. However, levels of genetic diversity and LD in field populations of the major human malaria parasite P. vivax remain little characterized.
   Results: We examined single-nucleotide polymorphisms (SNPs) and LD patterns across a 100-kb chromosome segment of P. vivax in 238 field isolates from areas of low to moderate malaria endemicity in South America and Asia, where LD tends to be more extensive than in holoendemic populations, and in two monkey-adapted strains (Salvador-I, from El Salvador, and Belem, from Brazil). We found varying levels of SNP diversity and LD across populations, with the highest diversity and strongest LD in the area of lowest malaria transmission. We found several clusters of contiguous markers with rare meiotic recombination and characterized a relatively conserved haplotype structure among populations, suggesting the existence of recombination hotspots in the genome region analyzed. Both silent and nonsynonymous SNPs revealed substantial between-population differentiation, which accounted for similar to 40% of the overall genetic diversity observed. Although parasites clustered according to their continental origin, we found evidence for substructure within the Brazilian population of P. vivax. We also explored between-population differentiation patterns revealed by loci putatively affected by natural selection and found marked geographic variation in frequencies of nucleotide substitutions at the pvmdr-1 locus, putatively associated with drug resistance.
   Conclusion: These findings support the feasibility of genome-wide association studies in carefully selected populations of P. vivax, using relatively low densities of markers, but underscore the risk of false positives caused by population structure at both local and regional levels.
C1 [Orjuela-Sanchez, Pamela; da Silva-Nunes, Monica; da Silva, Natal S.; Scopel, Kezia K. G.; Goncalves, Raquel M.; Ferreira, Marcelo U.] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, BR-05508900 Sao Paulo, Brazil.
   [Karunaweera, Nadira D.; Gunawardena, Sharmini] Univ Colombo, Fac Med, Dept Parasitol, Colombo 8, Sri Lanka.
   [da Silva-Nunes, Monica] Univ Fed Acre, Ctr Hlth Sci, BR-69915900 Rio Branco, Acre, Brazil.
   [Scopel, Kezia K. G.] Univ Fed Juiz de Fora, Inst Biol Sci, BR-36036330 Juiz De Fora, MG, Brazil.
   [Amaratunga, Chanaki; Sa, Juliana M.; Fairhust, Rick M.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.
   [Socheat, Duong] Natl Malaria Ctr, Phnom Penh 1, Cambodia.
   [Thavakodirasah, Thuraisamy; Galapaththy, Gawrie L. N.; Abeysinghe, Rabindra] Minist Hlth, Colombo 10, Sri Lanka.
   [Kawamoto, Fumihiko] Oita Univ, Inst Sci Res, Dept Social & Environm Med, Oita 8795593, Japan.
   [Wirth, Dyann F.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.
RP Ferreira, MU (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, BR-05508900 Sao Paulo, Brazil.
EM muferrei@usp.br
RI da Silva, Natal Santos/Y-1913-2019; da Silva, Natal Santos/E-9579-2015;
   da Silva-Nunes, Monica/A-1885-2008; Ferreira, Marcelo U/G-8289-2011
OI da Silva, Natal Santos/0000-0002-0856-1748; da Silva, Natal
   Santos/0000-0002-0856-1748; Ferreira, Marcelo U/0000-0002-5293-9090;
   Karunaweera, Nadira/0000-0003-3985-1817
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [RO1 AI
   075416-01, 5R03TW007966-02]; DFW; National Institute of Allergy and
   Infectious Diseases (NIAID)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID); Conselho Nacional de
   Desenvolvimento CientIfico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq) [470570/2006-7];
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [05/51988-0,
   07/51199-0]; Grants-in-Aid for Scientific ResearchMinistry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for
   the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [22406011] Funding Source: KAKEN; FOGARTY INTERNATIONAL CENTERUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Fogarty International Center (FIC) [R03TW007966,
   R03TW007966, R03TW007966] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI075416, R01AI075416, R01AI075416, R01AI075416] Funding Source: NIH
   RePORTER
FX This research was supported by funds from the National Institutes of
   Health (NIH) grants RO1 AI 075416-01 to MUF and 5R03TW007966-02 to NK
   and DFW, the Intramural Research Program of the National Institute of
   Allergy and Infectious Diseases (NIAID), NIH, to RMF, the Conselho
   Nacional de Desenvolvimento CientIfico e Tecnologico (CNPq) grant
   470570/2006-7 to MUF, and the Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) grants 05/51988-0 and 07/51199-0 to MUF. POS, NSS and
   MUF receive or received scholarships from CNPq and MdSN, KKGS and RMG
   receive or received scholarships from FAPESP. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript. We thank the patients from all field
   sites for their enthusiastic cooperation, the field work collaborators
   Rosely S. Malafronte and Adamilson Luis de Souza for their support in
   Brazil, Suon Seila and Sreng Sokunthea for their support in Cambodia,
   and H. Van Thien for his support in Vietnam, Maria Jose Menezes, Melissa
   da Silva Bastos and Michelle Cristina Brandi (University of Sao Paulo,
   Brazil) for excellent laboratory support, Apua Paquola for help in
   computational analyses and Cassiano Nunes Pereira for artwork.
CR Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247
   Anderson TJC, 2005, MOL BIOL EVOL, V22, P2362, DOI 10.1093/molbev/msi235
   ARNOT DE, 1990, MOL BIOCHEM PARASIT, V43, P147, DOI 10.1016/0166-6851(90)90140-H
   Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Brega S, 2005, J INFECT DIS, V191, P272, DOI 10.1086/426830
   Camargo AA, 1997, GENOMICS, V42, P467, DOI 10.1006/geno.1997.4758
   CAMARGO LMA, 2004, AM J TROP MED HYG, V51, P16
   Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327
   COLLINS WE, 1972, J PARASITOL, V58, P332, DOI 10.2307/3278097
   Cui LW, 2003, TRENDS PARASITOL, V19, P220, DOI 10.1016/S1471-4922(03)00085-0
   da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P624, DOI 10.4269/ajtmh.2008.79.624
   Da Silveira LA, 1999, INFECT IMMUN, V67, P5906, DOI 10.1128/IAI.67.11.5906-5916.1999
   Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499
   DELPORTILLO HA, 1991, P NATL ACAD SCI USA, V88, P4030, DOI 10.1073/pnas.88.9.4030
   Ding KY, 2003, BIOINFORMATICS, V19, P2147, DOI 10.1093/bioinformatics/btg276
   Duraisingh MT, 2005, MOL MICROBIOL, V57, P874, DOI 10.1111/j.1365-2958.2005.04748.x
   Escalante AA, 2004, TRENDS PARASITOL, V20, P388, DOI 10.1016/j.pt.2004.06.002
   Feng XR, 2003, P NATL ACAD SCI USA, V100, P8502, DOI 10.1073/pnas.1232502100
   Fernando SD, 2009, AM J TROP MED HYG, V81, P763, DOI 10.4269/ajtmh.2009.09-0042
   Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685
   Ferreira MU, 1998, J EUKARYOT MICROBIOL, V45, P131, DOI 10.1111/j.1550-7408.1998.tb05080.x
   Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8
   Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424
   Guerra CA, 2006, TRENDS PARASITOL, V22, P353, DOI 10.1016/j.pt.2006.06.006
   Gunawardena S, 2010, AM J TROP MED HYG, V82, P235, DOI 10.4269/ajtmh.2010.09-0588
   Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6
   Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x
   HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622
   Imwong M, 2007, INT J PARASITOL, V37, P1013, DOI 10.1016/j.ijpara.2007.02.010
   Karunaweera ND, 2008, GENE, V410, P105, DOI 10.1016/j.gene.2007.11.022
   Machado RLD, 2004, J INFECT DIS, V190, P1547, DOI 10.1086/424601
   MANTEL N, 1967, CANCER RES, V27, P209
   Marfurt J, 2008, J INFECT DIS, V198, P409, DOI 10.1086/589882
   Mu JB, 2005, PLOS BIOL, V3, P1734, DOI 10.1371/journal.pbio.0030335
   Nazarenko IA, 1997, NUCLEIC ACIDS RES, V25, P2516, DOI 10.1093/nar/25.12.2516
   Neafsey DE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r171
   NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503
   Nomura T, 2001, J INFECT DIS, V183, P1653, DOI 10.1086/320707
   Orjuela-Sanchez P, 2009, PARASITOLOGY, V136, P1097, DOI 10.1017/S0031182009990539
   Orjuela-Sanchez P, 2009, AM J TROP MED HYG, V81, P961, DOI 10.4269/ajtmh.2009.09-0337
   Orjuela-Sanchez P, 2009, ANTIMICROB AGENTS CH, V53, P3561, DOI 10.1128/AAC.00004-09
   Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190
   Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1
   Pritchard JK, 2000, GENETICS, V155, P945
   Sa JM, 2005, EXP PARASITOL, V109, P256, DOI 10.1016/j.exppara.2004.12.005
   Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01
   Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249
   Su XZ, 2007, NAT REV GENET, V8, P497, DOI 10.1038/nrg2126
   Sullivan JS, 2001, J PARASITOL, V87, P1398, DOI 10.1645/0022-3395(2001)087[1398:AOASOP]2.0.CO;2
   Suwanarusk R, 2008, J INFECT DIS, V198, P1558, DOI 10.1086/592451
   Suwanarusk R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001089
   Tchavtchitch M, 2001, MOL BIOCHEM PARASIT, V118, P211, DOI 10.1016/S0166-6851(01)00380-2
   Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268
   Udomsangpetch R, 2008, TRENDS PARASITOL, V24, P85, DOI 10.1016/j.pt.2007.09.010
   Wang N, 2002, AM J HUM GENET, V71, P1227, DOI 10.1086/344398
   WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]
   FSTAT VERSION 2 9 3
   POPTOOLS VERSION 2 7
NR 58
TC 40
Z9 42
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2156
J9 BMC GENET
JI BMC Genet.
PD JUL 13
PY 2010
VL 11
AR 65
DI 10.1186/1471-2156-11-65
PG 12
WC Genetics & Heredity
SC Genetics & Heredity
GA 632CL
UT WOS:000280397700001
PM 20626846
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU da Silva, NS
   da Silva-Nunes, M
   Malafronte, RS
   Menezes, MJ
   D'Arcadia, RR
   Komatsu, NT
   Scopel, KKG
   Braga, EM
   Cavasini, CE
   Cordeiro, JA
   Ferreira, MU
AF da Silva, Natal S.
   da Silva-Nunes, M.
   Malafronte, Rosely S.
   Menezes, Maria J.
   D'Arcadia, Rosane R.
   Komatsu, Natalia T.
   Scopel, Kezia K. G.
   Braga, Erika M.
   Cavasini, Carlos E.
   Cordeiro, Jose A.
   Ferreira, Marcelo U.
TI Epidemiology and control of frontier malaria in Brazil: lessons from
   community-based studies in rural Amazonia
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Plasntodium vivax; Plasmodium falciparum; Epidemiology; Cohort study;
   Spatial clustering; Amazonia
ID PLASMODIUM-VIVAX; HYPOENDEMIC MALARIA; ANOPHELES-DARLINGI; KAREN
   POPULATION; PERUVIAN AMAZON; FALCIPARUM; VECTOR; REGION; INTERVENTIONS;
   INFECTION
AB We describe the epidemiology of malaria in a frontier agricultural settlement in Brazilian Amazonia. We analysed the incidence of slide-confirmed symptomatic infections diagnosed between 2001 and 2006 in a cohort of 531 individuals (2281.53 person-years of follow-up) and parasite prevalence data derived from four cross-sectional surveys. Overall, the incidence rates of Plasmodium vivax and P. falciparaum were 20.6/100 and 6.8/100 person-years at risk, respectively, with a marked decline in the incidence of both species (81.4 and 56.8%, respectively) observed between 2001 and 2006. PCR revealed 5.4-fold more infections than conventional microscopy in population-wide cross-sectional surveys carried out between 2004 and 2006 (average prevalence, 11.3 vs. 2.0%). Only 27.2% of PCR-positive (but 73.3% of slide-positive) individuals had symptoms when enrolled, indicating that asymptomatic carriage of low-grade parasitaemias is a common phenomenon in frontier settlements. A circular cluster comprising 22.3% of the households, all situated in the area of most recent occupation, comprised 69.1% of all malaria infections diagnosed during the follow-up, with malaria incidence decreasing exponentially with distance from the cluster centre. By targeting one-quarter of the households, with selective indoor spraying or other house-protection measures, malaria incidence could be reduced by more than two-thirds in this community. (C) 2010 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.
C1 [da Silva, Natal S.; da Silva-Nunes, M.; Menezes, Maria J.; D'Arcadia, Rosane R.; Komatsu, Natalia T.; Scopel, Kezia K. G.; Ferreira, Marcelo U.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508900 Sao Paulo, Brazil.
   [da Silva-Nunes, M.] Univ Fed Acre, Ctr Ciencias Saude & Desporto, Rio Branco, AC, Brazil.
   [Malafronte, Rosely S.] Inst Med Trop Sao Paulo, Lab Protozool, Sao Paulo, Brazil.
   [Malafronte, Rosely S.] Univ Sao Paulo, Fac Med, Dept Doencas Infecciosas & Parasitarias, Sao Paulo, Brazil.
   [Scopel, Kezia K. G.; Braga, Erika M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.
   [Cavasini, Carlos E.] Fac Med Sao Jose do Rio Preto, Dept Doencas Dermatol Infecciosas & Parasitarias, Sao Jose Do Rio Preto, SP, Brazil.
   [Cordeiro, Jose A.] Fac Med Sao Jose do Rio Preto, Dept Epidemiol & Saude Colet, Sao Jose Do Rio Preto, SP, Brazil.
RP Ferreira, MU (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, Av Prof Lineu Prestes 1374, BR-05508900 Sao Paulo, Brazil.
EM muferrei@usp.br
RI Ferreira, Marcelo U/G-8289-2011; da Silva-Nunes, Monica/A-1885-2008;
   Malafronte, Rosely/C-3138-2013; Braga, Erika M/A-6776-2008; da Silva,
   Natal Santos/Y-1913-2019; da Silva, Natal Santos/E-9579-2015
OI Ferreira, Marcelo U/0000-0002-5293-9090; Braga, Erika
   M/0000-0001-5550-7157; da Silva, Natal Santos/0000-0002-0856-1748; da
   Silva, Natal Santos/0000-0002-0856-1748
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [470067/2004-7]; Fundacao de Amparo Pesquisa do Estado de Sao
   Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [03/09719-6, 05/51988-0]; FAPESP (MdSN and RRD'A)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); CNPqNational Council
   for Scientific and Technological Development (CNPq); CAPESCAPES
FX This work received financial support from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq, 470067/2004-7) and
   Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP, 03/09719-6
   and 05/51988-0). Scholarships from FAPESP (MdSN and RRD'A), CNPq (NRdS,
   NTK, EMB and MUF) and CAPES (KKGS) are also acknowledged.
CR Aguas R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001767
   Alves FP, 2005, J MED ENTOMOL, V42, P777, DOI 10.1603/0022-2585(2005)042[0777:ACOPSA]2.0.CO;2
   Alves FP, 2002, AM J TROP MED HYG, V66, P641, DOI 10.4269/ajtmh.2002.66.641
   Camargo LMA, 1996, AM J TROP MED HYG, V55, P32, DOI 10.4269/ajtmh.1996.55.32
   Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401
   Chanon KE, 2003, INT J HYG ENVIR HEAL, V206, P387, DOI 10.1078/1438-4639-00235
   CHARLWOOD JD, 1989, ANN TROP MED PARASIT, V83, P569, DOI 10.1080/00034983.1989.11812389
   Conteh L, 2004, TROP MED INT HEALTH, V9, P125, DOI 10.1046/j.1365-3156.2003.01150.x
   Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001
   da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P624, DOI 10.4269/ajtmh.2008.79.624
   da Silva-Nunes M, 2007, MEM I OSWALDO CRUZ, V102, P341, DOI 10.1590/S0074-02762007005000051
   de Castro MC, 2007, HEALTH PLACE, V13, P368, DOI 10.1016/j.healthplace.2006.03.006
   Eriksson C, 2000, SCAND J PUBLIC HEALT, V28, P298, DOI 10.1177/14034948000280040101
   Katsuragawa TH, 2009, CAD SAUDE PUBLICA, V25, P1486, DOI 10.1590/S0102-311X2009000700006
   KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809
   Ladeia-Andrade S, 2009, AM J TROP MED HYG, V80, P452, DOI 10.4269/ajtmh.2009.80.452
   Loiola Carlos Catão Prates, 2002, Rev Panam Salud Publica, V11, P235, DOI 10.1590/S1020-49892002000400005
   Luxemburger C, 1996, T ROY SOC TROP MED H, V90, P105, DOI 10.1016/S0035-9203(96)90102-9
   Macauley C, 2005, SOC SCI MED, V60, P563, DOI 10.1016/j.socscimed.2004.05.025
   Maitland K, 1996, T ROY SOC TROP MED H, V90, P614, DOI 10.1016/S0035-9203(96)90406-X
   MARCELO L, 1994, AM J TROP MED HYG, V51, P16, DOI 10.4269/ajtmh.1994.51.16
   MARQUES AC, 1987, PARASITOL TODAY, V3, P166, DOI 10.1016/0169-4758(87)90170-0
   Najera J. A., 2001, Parassitologia (Rome), V43, P1
   Orjuela-Sanchez P, 2009, AM J TROP MED HYG, V81, P961, DOI 10.4269/ajtmh.2009.09-0337
   *PAN AM HLTH ORG, 2008, MAL PROGR REP 2007
   Phimpraphi W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-99
   Roshanravan B, 2003, AM J TROP MED HYG, V69, P45, DOI 10.4269/ajtmh.2003.69.45
   Scopel KKG, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-8
   Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3
   Win TT, 2002, TROP MED INT HEALTH, V7, P231, DOI 10.1046/j.1365-3156.2002.00857.x
NR 30
TC 43
Z9 43
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD MAY
PY 2010
VL 104
IS 5
BP 343
EP 350
DI 10.1016/j.trstmh.2009.12.010
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 599AD
UT WOS:000277881200006
PM 20106494
DA 2020-12-08
ER

PT J
AU Albrecht, L
   Castineiras, C
   Carvalho, BO
   Ladeia-Andrade, S
   da Silva, NS
   Hoffmann, EHE
   dalla Martha, RC
   Costa, FTM
   Wunderlich, G
AF Albrecht, Letusa
   Castineiras, Catarina
   Carvalho, Bruna O.
   Ladeia-Andrade, Simone
   da Silva, Natal Santos
   Hoffmann, Erika H. E.
   dalla Martha, Rosimeire C.
   Costa, Fabio T. M.
   Wunderlich, Gerhard
TI The South American Plasmodium falciparum var gene repertoire is limited,
   highly shared and possibly lacks several antigenic types
SO GENE
LA English
DT Article
DE Antigenic variation; var; PfEMP1
ID ECTOPIC RECOMBINATION; IMMUNE EVASION; AMAZON REGION; MALARIA; SURFACE;
   DIVERSITY; TRANSCRIPTION; POPULATIONS; PFEMP1; BRAZIL
AB The Plasmodium falciparum var gene family encodes large variant antigens, which are important virulence factors, and also targets of the humoral host response. The frequently observed mild outcomes of falciparum malaria in many places of the Amazon area prompted us to ask whether a globally restricted variant (var) gene repertoire is present in currently circulating and older isolates of this area. By exhaustive analysis of var gene tags from 89 isolates and clones taken during many years from all over the Brazilian Amazon, we estimate that there are probably no more than 350-430 distinct sequence types, less than for any similar sized area studied so far. Detailed analysis of the var tags from genetically distinct clones obtained from single isolates revealed restricted and redundant repertoires suggesting either a low incidence of infective bites or restricted variant gene diversity in inoculated parasites. Additionally, we found a structuring of var gene repertoires observed as a higher pairwise typing sharing in isolates from the same microregion compared to isolates from different regions. Fine analysis of translated var tags revealed that certain Distinct Sequence Identifiers (DSIDs) were differently represented in Brazilian/South American isolates when compared to datasets from other continents. By global alignment of worldwide var DBL alpha sequences and sorting in groups with more than 76% identity, 125 clusters were formed and more than half of all genes were found in nine clusters with 50 or more sequences. While Brazilian/South American sequences were represented only in 64 groups, African sequences were found in the majority of clusters. DSID type 1 related sequences accumulated almost completely in one single cluster, indicating that limited recombination occurs in these specific var gene types. These data demonstrate the so far highest pairwise type sharing values for the var gene family in isolates from all over an entire subcontinent. The apparent lack of specific sequences types suggests that the P. falciparum transmission dynamics in the whole Amazon are probably different from any other endemic region studied and possibly interfere with the parasite's ability to efficiently diversify its variant gene repertoires. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Albrecht, Letusa; Castineiras, Catarina; Ladeia-Andrade, Simone; da Silva, Natal Santos; Wunderlich, Gerhard] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, BR-05508900 Sao Paulo, Brazil.
   [Carvalho, Bruna O.; Costa, Fabio T. M.] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Genet Evolut & Bioagents, Campinas, SP, Brazil.
   [Hoffmann, Erika H. E.] Univ Sao Paulo, Inst Trop Med, BR-05508900 Sao Paulo, Brazil.
   [dalla Martha, Rosimeire C.] Ctr Res Trop Med CEPEM, Porto Velho, Brazil.
RP Wunderlich, G (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Av Prof Lineu Prestes 1374, BR-05508900 Sao Paulo, Brazil.
EM gwunder@usp.br
RI da Silva, Natal Santos/E-9579-2015; Wunderlich, Gerhard/G-8245-2012;
   Albrecht, Letusa/I-1837-2012; da Silva, Natal Santos/Y-1913-2019; Costa,
   Fabio/E-1181-2012
OI da Silva, Natal Santos/0000-0002-0856-1748; Wunderlich,
   Gerhard/0000-0003-1724-0337; Albrecht, Letusa/0000-0001-6406-2057; da
   Silva, Natal Santos/0000-0002-0856-1748; Costa,
   Fabio/0000-0001-9969-7300; ladeia-andrade, simone/0000-0003-0912-5937
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPqNational Council for Scientific and Technological Development (CNPq)
FX The authors thank Wolfgang Fischer and Marcio Yamamoto for help with
   sequencing. LA and BC received a FAPESP postgraduate fellowship, CC
   received a CNPq fellowship. This work was supported by a FAPESP grant to
   GW. FTMC and GW are CNPq fellows.
CR Albrecht L, 2006, MOL BIOCHEM PARASIT, V150, P157, DOI 10.1016/j.molbiopara.2006.07.007
   Alves FP, 2002, AM J TROP MED HYG, V66, P641, DOI 10.4269/ajtmh.2002.66.641
   Arez AP, 1999, PARASITOLOGY, V118, P347, DOI 10.1017/S0031182099003972
   Barry AE, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030034
   BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3
   BOYLE JS, 1995, TRENDS GENET, V11, P8, DOI 10.1016/S0168-9525(00)88977-5
   Bull PC, 2007, MOL BIOCHEM PARASIT, V154, P98, DOI 10.1016/j.molbiopara.2007.03.011
   Bull PC, 2005, PLOS PATHOG, V1, P202, DOI 10.1371/journal.ppat.0010026
   Cham GKK, 2009, J IMMUNOL, V183, P3356, DOI 10.4049/jimmunol.0901331
   Colwell RK, 2006, STAT ESTIMATION SPEC
   Craig A, 2001, MOL BIOCHEM PARASIT, V115, P129, DOI 10.1016/S0166-6851(01)00275-4
   da Silva-Nunes M, 2007, MEM I OSWALDO CRUZ, V102, P341, DOI 10.1590/S0074-02762007005000051
   Duffy MF, 2009, J MOL BIOL, V389, P453, DOI 10.1016/j.jmb.2009.04.032
   Durham AM, 2005, BIOINFORMATICS, V21, P2812, DOI 10.1093/bioinformatics/bti424
   Fowler EV, 2002, MOL BIOCHEM PARASIT, V120, P117, DOI 10.1016/S0166-6851(01)00443-1
   Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531
   Hoffmann EHE, 2006, GENE, V376, P224, DOI 10.1016/j.gene.2006.03.011
   Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274
   Kaestli M, 2006, J INFECT DIS, V193, P1567, DOI 10.1086/503776
   Kirchgatter K, 2002, MOL MED, V8, P16, DOI 10.1007/BF03401999
   Kraemer SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-45
   Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005
   Ladeia-Andrade S, 2007, MEM I OSWALDO CRUZ, V102, P943, DOI 10.1590/S0074-02762007000800009
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   LEECH JH, 1984, J EXP MED, V159, P1567, DOI 10.1084/jem.159.6.1567
   Machado RLD, 2004, J INFECT DIS, V190, P1547, DOI 10.1086/424601
   MARCELO L, 1994, AM J TROP MED HYG, V51, P16, DOI 10.4269/ajtmh.1994.51.16
   Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x
   Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a
   Moll K., 2008, METHODS MALARIA RES
   Normark J, 2007, P NATL ACAD SCI USA, V104, P15835, DOI 10.1073/pnas.0610485104
   Peters J, 2002, P NATL ACAD SCI USA, V99, P10689, DOI 10.1073/pnas.162349899
   Razakandrainibe FG, 2005, P NATL ACAD SCI USA, V102, P17388, DOI 10.1073/pnas.0508871102
   ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0
   Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320
   SAWYER D R, 1986, Southeast Asian Journal of Tropical Medicine and Public Health, V17, P342
   Scherf A, 2006, CELL, V124, P251, DOI 10.1016/j.cell.2006.01.004
   Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418
   Tami A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-7
   Taylor HM, 2000, MOL BIOCHEM PARASIT, V105, P13, DOI 10.1016/S0166-6851(99)00159-0
   Taylor HM, 2000, MOL BIOCHEM PARASIT, V110, P391, DOI 10.1016/S0166-6851(00)00286-3
   Ward CP, 1999, MOL BIOCHEM PARASIT, V102, P167, DOI 10.1016/S0166-6851(99)00106-1
NR 42
TC 19
Z9 19
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD MAR 15
PY 2010
VL 453
IS 1-2
BP 37
EP 44
DI 10.1016/j.gene.2010.01.001
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA 573UA
UT WOS:000275939200004
PM 20079817
DA 2020-12-08
ER

PT J
AU Orjuela-Sanchez, P
   da Silva, NS
   da Silva-Nunes, M
   Ferreira, MU
AF Orjuela-Sanchez, Pamela
   da Silva, Natal Santos
   da Silva-Nunes, Monica
   Ferreira, Marcelo Urbano
TI Recurrent Parasitemias and Population Dynamics of Plasmodium vivax
   Polymorphisms in Rural Amazonia
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID TRANSMISSION DYNAMICS; MOLECULAR ANALYSIS; MALARIA; RELAPSES; BRAZIL;
   CHLOROQUINE; PRIMAQUINE; INFECTION; MARKERS; HYPNOZOITES
AB Clinical trials documented alarming post-treatment Plasmodium vivax recurrence rates caused by recrudescence of surviving asexual blood stages, relapse from hypnozoites, or new infections. Here we describe high rates of P vivax recurrence (26-40% 180 days after treatment) in two cohorts of rural Amazonians exposed to low levels of malaria transmission after a vivax malaria episode treated with chloroquine-primaquine. Microsatellite analysis of 28 paired acute infection and recurrence parasites showed only two pairs of identical haplotypes (consistent with recrudescences or reactivation of homologous hypnozoites) and four pairs of related haplotypes (sharing alleles at 11-13 of 14 microsatellites analyzed). Local isolates of P vivax were extraordinarily diverse and rarely shared the same haplotype, indicating that frequent recurrences did not favor the persistence or reappearance of clonal lineages of parasites in the Population. This fast haplotype replacement rate may represent the typical population dynamics Of neutral polymorphisms in parasites from low-endemicity areas.
C1 [Orjuela-Sanchez, Pamela; da Silva, Natal Santos; da Silva-Nunes, Monica; Ferreira, Marcelo Urbano] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, BR-05508900 Sao Paulo, Brazil.
   [da Silva-Nunes, Monica] Univ Fed Acre, Dept Hlth Sci, BR-69915900 Rio Branco, AC, Brazil.
RP Ferreira, MU (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Av Prof Lineu Prestes 1374, BR-05508900 Sao Paulo, Brazil.
EM pamelaorjuela@gmail.com; natalss@gmail.com; msnunes1@yahoo.com.br;
   muferrei@usp.br
RI da Silva, Natal Santos/E-9579-2015; da Silva, Natal Santos/Y-1913-2019;
   da Silva-Nunes, Monica/A-1885-2008; Ferreira, Marcelo U/G-8289-2011
OI da Silva, Natal Santos/0000-0002-0856-1748; da Silva, Natal
   Santos/0000-0002-0856-1748; Ferreira, Marcelo U/0000-0002-5293-9090
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [RO1 AI 075416-01];
   Conselho Nacional de Desenvolvimento Cientifico c Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [470570/2006-7]; Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [05//51988-0, 07/51199-0]; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI075416, R01AI075416,
   R01AI075416, R01AI075416] Funding Source: NIH RePORTER
FX This study was funded by research grants from the National Institutes of
   Health (RO1 AI 075416-01), the Conselho Nacional de Desenvolvimento
   Cientifico c Tecnologico (CNPq, 470570/2006-7) and the Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, 05//51988-0 and
   07/51199-0). P.O.S., N.S.d.S.. and M.U.F. currently receive scholarships
   from CNPq; M.d.S.-N. received a PhD scholarship from FAPESP.
CR Akhavan D, 1999, SOC SCI MED, V49, P1385, DOI 10.1016/S0277-9536(99)00214-2
   Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552
   Baird JK, 2008, NEW ENGL J MED, V359, P2601, DOI 10.1056/NEJMe0808729
   Baird JK, 2004, ANTIMICROB AGENTS CH, V48, P4075, DOI 10.1128/AAC.48.11.4075-4083.2004
   Barat LM, 2006, AM J TROP MED HYG, V74, P12, DOI 10.4269/ajtmh.2006.74.12
   BOULOS M, 1991, REV I MED TROP, V33, P143, DOI 10.1590/S0036-46651991000200009
   Bray PG, 2005, BIOCHEM PHARMACOL, V70, P1158, DOI 10.1016/j.bcp.2005.07.021
   Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327
   Ceravolo IP, 2009, CLIN EXP IMMUNOL, V156, P502, DOI 10.1111/j.1365-2249.2009.03931.x
   Chen NH, 2007, J INFECT DIS, V195, P934, DOI 10.1086/512242
   Craig AA, 1996, J INFECT DIS, V174, P373, DOI 10.1093/infdis/174.2.373
   da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P624, DOI 10.4269/ajtmh.2008.79.624
   Ladislau JLD, 2006, EPIDEMIOL SERV SAUDE, V15, P9
   Duarte EC, 2001, AM J TROP MED HYG, V65, P471, DOI 10.4269/ajtmh.2001.65.471
   Feachem R, 2008, LANCET, V371, P1633, DOI 10.1016/S0140-6736(08)60424-9
   Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004
   Ferrari Andrea, 2007, Paediatr Drugs, V9, P239, DOI 10.2165/00148581-200709040-00005
   Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685
   de Santana FS, 2007, EMERG INFECT DIS, V13, P1125, DOI 10.3201/eid1307.061386
   *FUND NAC SAUD, 2001, DIAGN TRAT MAL
   Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847
   Havryliuk T, 2008, EXP PARASITOL, V120, P330, DOI 10.1016/j.exppara.2008.08.012
   Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241
   Joy DA, 2008, MOL BIOL EVOL, V25, P1245, DOI 10.1093/molbev/msn073
   Karunajeewa HA, 2008, NEW ENGL J MED, V359, P2545, DOI 10.1056/NEJMoa0804915
   Karunaweera ND, 2007, MOL ECOL NOTES, V7, P172, DOI 10.1111/j.1471-8286.2006.01534.x
   Karunaweera ND, 2008, GENE, V410, P105, DOI 10.1016/j.gene.2007.11.022
   Kirchgatter K, 1998, J INFECT DIS, V177, P511, DOI 10.1086/517389
   Koepfli C, 2009, J INFECT DIS, V199, P1074, DOI 10.1086/597303
   Loiola Carlos Catão Prates, 2002, Rev Panam Salud Publica, V11, P235, DOI 10.1590/S1020-49892002000400005
   MANTEL N, 1967, CANCER RES, V27, P209
   MARQUES AC, 1987, PARASITOL TODAY, V3, P166, DOI 10.1016/0169-4758(87)90170-0
   MENDIS K, 2009, TROP MED INT HEALTH, V14, P1
   *PAHO, 2008, MAL PROGR REP
   Pukrittayakamee S, 2000, ANTIMICROB AGENTS CH, V44, P1680, DOI 10.1128/AAC.44.6.1680-1685.2000
   PUKRITTAYAKAMEE S, 1994, J INFECT DIS, V169, P932, DOI 10.1093/infdis/169.4.932
   Sattabongkot J, 2004, TRENDS PARASITOL, V20, P192, DOI 10.1016/j.pt.2004.02.001
   Tantular IS, 2003, TROP MED INT HEALTH, V8, P569, DOI 10.1046/j.1365-3156.2003.01055.x
   Villalobos-Salcedo JM, 2000, ANN TROP MED PARASIT, V94, P749, DOI 10.1080/00034980020027960
   Win TT, 2002, TROP MED INT HEALTH, V7, P231, DOI 10.1046/j.1365-3156.2002.00857.x
NR 40
TC 56
Z9 57
U1 0
U2 5
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD DEC
PY 2009
VL 81
IS 6
BP 961
EP 968
DI 10.4269/ajtmh.2009.09-0337
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 531YN
UT WOS:000272709600007
PM 19996423
OA Bronze
DA 2020-12-08
ER

PT J
AU Orjuela-Sanchez, P
   Da Silva-Nunes, M
   Da Silva, NS
   Scopel, KKG
   Goncalves, RM
   Malafronte, RS
   Ferreira, MU
AF Orjuela-Sanchez, P.
   Da Silva-Nunes, M.
   Da Silva, N. S.
   Scopel, K. K. G.
   Goncalves, R. M.
   Malafronte, R. S.
   Ferreira, M. U.
TI Population dynamics of genetically diverse Plasmodium falciparum
   lineages: community-based prospective study in rural Amazonia
SO PARASITOLOGY
LA English
DT Article
DE Plasmodium falciparum; Population dynamics; polymorphism; parasite
   lineages
ID MEROZOITE SURFACE PROTEIN-2; TRANSMISSION DYNAMICS; MALARIA VACCINE;
   MICROSATELLITE MARKERS; ANTIBODY RECOGNITION; SEQUENCE DIVERSITY;
   NATURAL-SELECTION; ALLELIC DIVERSITY; SOUTHERN VIETNAM; EVOLUTION
AB Temporal changes in the prevalence of antigenic variants in Plasmodium falciparum populations have been interpreted as evidence of immune-mediated frequency-dependent selection, but evolutively neutral processes may generate similar patterns of serotype replacement. Over 4 years, we investigated the population dynamics of P. falciparum polymorphisms the community level by using 11 putatively neutral microsatellite markers. Plasmodium falciparum Populations were less diverse than sympatric P. vivax isolates, with less multiple-clone infections, lower number of alleles per locus and lower Virtual heterozygosity, but both species showed significant multilocus linkage disequilibrium. Evolutively neutral P. falciparum polymorphisms showed a high turnover rate, with few lineages persisting for several months in the population. Similar results had previously been obtained, in the same community, for sympatric P. vivax isolates. In contrast, the prevalence of the 2 dimorphic types of a major antigen, MSP-2, remained remarkably stable throughout the Study period. We Suggest that the relatively fast turnover of parasite lineages represents the typical population dynamics of neutral polymorphisms in small populations, with clear implications for the detection of frequency-dependent selection of polymorphisms.
C1 [Orjuela-Sanchez, P.; Da Silva-Nunes, M.; Da Silva, N. S.; Scopel, K. K. G.; Goncalves, R. M.; Ferreira, M. U.] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, BR-05508900 Sao Paulo, Brazil.
   [Da Silva-Nunes, M.] Univ Fed Acre, Dept Hlth Sci, Rio Branco, Brazil.
   [Malafronte, R. S.] Univ Sao Paulo, Inst Trop Med Sao Paulo, Lab Protozool, BR-05508900 Sao Paulo, Brazil.
   [Malafronte, R. S.] Univ Sao Paulo, Fac Med, Dept Infect & Parasit Dis, BR-05508900 Sao Paulo, Brazil.
RP Ferreira, MU (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Av Prof Lineu Prestes 1374, BR-05508900 Sao Paulo, Brazil.
EM muferrei@usp.br
RI da Silva, Natal Santos/Y-1913-2019; da Silva, Natal Santos/E-9579-2015;
   Malafronte, Rosely/C-3138-2013; da Silva-Nunes, Monica/A-1885-2008;
   Ferreira, Marcelo U/G-8289-2011
OI da Silva, Natal Santos/0000-0002-0856-1748; da Silva, Natal
   Santos/0000-0002-0856-1748; Ferreira, Marcelo U/0000-0002-5293-9090
FU Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico(CNPq)National Council for Scientific and Technological
   Development (CNPq) [470570/2006-7]; Fundacao de Amparo A Pesquisa do
   Estado de Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [07/51199-0]; National Institutes of Health of USA
   (NIH)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [RO1 AI 075416-01]; NATIONAL INSTITUTE
   OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [R01AI075416,
   R01AI075416, R01AI075416, R01AI075416] Funding Source: NIH RePORTER
FX This study was funded by grants from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq, 470570/2006-7), Fundacao
   de Amparo A Pesquisa do Estado de Sao Paulo (FAPESP, 07/51199-0), and
   National Institutes of Health of USA (NIH, RO1 AI 075416-01). P.O.S.,
   N.S. dS., and M. U. F. receive scholarships from CNPq; Md. S.N., K. K.
   G. S., and R. M. G. receive or received scholarships from FAPESP. We
   thank the population of Granada for their enthusiastic participation in
   the Study; Adamilson L. de Souza, Valdecir E. da Silva, Maria Jose
   Menezes, and Pascoal T. Muniz for help in fieldwork; and Guilherme L. S.
   F. Renoldi (CNPq scholarship recipient) and Carmen S. A. Takata for help
   with microsatellite typing.
CR Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247
   Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552
   Awadalla P, 2001, TRENDS PARASITOL, V17, P351, DOI 10.1016/S1471-4922(01)02034-7
   CONWAY DJ, 1992, INFECT IMMUN, V60, P1122, DOI 10.1128/IAI.60.3.1122-1127.1992
   Conway DJ, 1997, PARASITOL TODAY, V13, P26, DOI 10.1016/S0169-4758(96)10077-6
   da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P624, DOI 10.4269/ajtmh.2008.79.624
   Da Silveira LA, 1999, INFECT IMMUN, V67, P5906, DOI 10.1128/IAI.67.11.5906-5916.1999
   Eisen D, 1998, INFECT IMMUN, V66, P239, DOI 10.1128/IAI.66.1.239-246.1998
   Farnert A, 2008, TRENDS PARASITOL, V24, P340, DOI 10.1016/j.pt.2008.04.008
   FELGER I, 1999, T ROYAL SOC TROPI S1, V93
   Ferreira MU, 2007, EXP PARASITOL, V115, P32, DOI 10.1016/j.exppara.2006.05.003
   Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685
   Ferreira MU, 1998, J EUKARYOT MICROBIOL, V45, P131, DOI 10.1111/j.1550-7408.1998.tb05080.x
   Fluck C, 2004, INFECT IMMUN, V72, P6300, DOI 10.1128/IAI.72.11.6300-6305.2004
   FORSYTH KP, 1988, PHILOS T ROY SOC B, V321, P485, DOI 10.1098/rstb.1988.0104
   Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342
   GUPTA S, 1994, P ROY SOC B-BIOL SCI, V256, P231, DOI 10.1098/rspb.1994.0075
   Gupta S, 1998, SCIENCE, V280, P912, DOI 10.1126/science.280.5365.912
   Gupta S, 2001, TRENDS MICROBIOL, V9, P181, DOI 10.1016/S0966-842X(01)01986-2
   Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847
   Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x
   Jalloh A, 2006, J CLIN MICROBIOL, V44, P1229, DOI 10.1128/JCM.44.4.1229-1235.2006
   Kumkhaek C, 2005, J IMMUNOL, V175, P3935, DOI 10.4049/jimmunol.175.6.3935
   Lipsitch M, 2007, J R SOC INTERFACE, V4, P787, DOI 10.1098/rsif.2007.0229
   MANTEL N, 1967, CANCER RES, V27, P209
   *MIN HLTH BRAZ, 2001, MAN ANT THER
   Neafsey DE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r171
   Pritchard JK, 2000, GENETICS, V155, P945
   SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384
   Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351
   TAYLOR RR, 1995, INFECT IMMUN, V63, P4382, DOI 10.1128/IAI.63.11.4382-4388.1995
   Tonon AP, 2004, EXP PARASITOL, V108, P114, DOI 10.1016/j.exppara.2004.08.001
NR 32
TC 23
Z9 23
U1 0
U2 4
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0031-1820
EI 1469-8161
J9 PARASITOLOGY
JI Parasitology
PD SEP
PY 2009
VL 136
IS 10
BP 1097
EP 1105
DI 10.1017/S0031182009990539
PG 9
WC Parasitology
SC Parasitology
GA 492GW
UT WOS:000269644100002
PM 19631016
OA Green Accepted
DA 2020-12-08
ER

PT J
AU Ferreira, MU
   Hiramoto, RM
   Aureliano, DP
   da Silva-Nunes, M
   da Silva, NS
   Malafronte, RS
   Muniz, PT
AF Ferreira, Marcelo U.
   Hiramoto, Roberto M.
   Aureliano, Debora P.
   da Silva-Nunes, Monica
   da Silva, Natal S.
   Malafronte, Rosely S.
   Muniz, Pascoal T.
TI A Community-based Survey of Human Toxoplasmosis in Rural Amazonia:
   Seroprevalence, Seroconversion Rate, and Associated Risk Factors
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID GONDII INFECTION; PREGNANT-WOMEN; CONGENITAL TOXOPLASMOSIS; WATERBORNE
   TOXOPLASMOSIS; SPATIAL-DISTRIBUTION; BRAZIL; SEROEPIDEMIOLOGY;
   ANTIBODIES; ANIMALS; MALARIA
AB IgG antibodies to Toxoplasma gondii were detected in, March-April 2004, in 65.8% (95% confidence interval, 60.8-70.8%) of 342 systematically sampled subjects 5-90 years of age (87.5% of the eligible) living in a rural settlement in Amazonia, with a seroconversion rate of 9% over I year of follow-up of 99 seronegative subjects. Multiple logistic regression analysis identified age as the only significant independent predictor of seropositivity at the baseline. Each additional year of age increases the odds of being seropositive by 6%, and 76.8% of the subjects are expected to be seropositive at 30 years of age. A single high-prevalence spatial cluster, comprising 11.9% of the seropositive subjects, was detected in the area; households in the cluster were less likely to have dogs as pets and their heads had a lower education level, when compared with households located outside the cluster. The challenges for preventing human toxoplasmosis in tropical rural settings are discussed.
C1 [Ferreira, Marcelo U.; da Silva-Nunes, Monica; da Silva, Natal S.] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, BR-05508900 Sao Paulo, Brazil.
   [da Silva-Nunes, Monica; Muniz, Pascoal T.] Univ Fed Acre, Dept Hlth Sci, BR-69915900 Rio Branco, AC, Brazil.
   [Hiramoto, Roberto M.; Aureliano, Debora P.] Adolfo Lutz Inst, Sect Syst Parasit Dis, BR-01246000 Sao Paulo, Brazil.
   [Malafronte, Rosely S.] Inst Trop Med Sao Paulo, BR-05403000 Sao Paulo, Brazil.
RP Ferreira, MU (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Av Prof Lineu Prestes 1374, BR-05508900 Sao Paulo, Brazil.
EM muferrei@usp.br; hiramoto@usp.br; dpicansso@hotmail.com;
   natalss@gmail.com; rmalafronte@usp.br; pascoal@ufac.br
RI da Silva, Natal Santos/E-9579-2015; Ferreira, Marcelo U/G-8289-2011; da
   Silva-Nunes, Monica/A-1885-2008; da Silva, Natal Santos/Y-1913-2019;
   Hiramoto, Roberto/H-6775-2012; Malafronte, Rosely/C-3138-2013
OI da Silva, Natal Santos/0000-0002-0856-1748; Ferreira, Marcelo
   U/0000-0002-5293-9090; da Silva, Natal Santos/0000-0002-0856-1748; 
FU Fundaqa de Amparo A Pesquisa do Estado de Saa Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [05/51988-0]; NSdS;
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   BrazilNational Council for Scientific and Technological Development
   (CNPq)
FX This study was supported by a grant from the Fundaqa de Amparo A
   Pesquisa do Estado de Saa Paulo (FAPESP, 05/51988-0). MdSN was supported
   by a PhD scholarship from FAPESP; NSdS and MUF received scholarships
   from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq), Brazil.
CR Alvarado-Esquivel C, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-113
   Bahia-Oliveira LMG, 2003, EMERG INFECT DIS, V9, P55
   BARUZZI RG, 1970, REV INST MED TROP SP, V14, P92
   CAMARGO ME, 1978, INFECT IMMUN, V21, P55, DOI 10.1128/IAI.21.1.55-58.1978
   Cavalcante GT, 2006, J PARASITOL, V92, P647, DOI 10.1645/GE-774R.1
   Chintana T., 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P383
   Cook AJC, 2000, BRIT MED J, V321, P142, DOI 10.1136/bmj.321.7254.142
   Coutinho S G, 1981, Rev Inst Med Trop Sao Paulo, V23, P48
   da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P624, DOI 10.4269/ajtmh.2008.79.624
   De la Rosa M, 1999, MEDICINA-BUENOS AIRE, V59, P759
   de Oliveira LN, 2009, J PARASITOL, V95, P235, DOI 10.1645/GE-1730.1
   Dubey JP, 2004, VET PARASITOL, V126, P57, DOI 10.1016/j.vetpar.2004.09.005
   Dubey JP, 2000, BRIT MED J, V321, P127, DOI 10.1136/bmj.321.7254.127
   Elsheikha HM, 2008, PUBLIC HEALTH, V122, P335, DOI 10.1016/j.puhe.2007.08.009
   Ertug S, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-66
   FERREIRA MU, 1994, ACTA TROP, V58, P73, DOI 10.1016/0001-706X(94)90122-8
   Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003
   Francisco Fabio de Moraes, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P167, DOI 10.1590/S0036-46652006000300009
   FRENKEL JK, 1975, AM J TROP MED HYG, V24, P439, DOI 10.4269/ajtmh.1975.24.439
   Garcia J L, 1999, Rev Panam Salud Publica, V6, P157
   Guimaraes A. C. S., 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P479, DOI 10.1590/S0036-46651993000600001
   Heukelbach J, 2007, EMERG INFECT DIS, V13, P287, DOI 10.3201/eid1302.060686
   Kapperud G, 1996, AM J EPIDEMIOL, V144, P405, DOI 10.1093/oxfordjournals.aje.a008942
   KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809
   Leser P G, 1977, Rev Inst Med Trop Sao Paulo, V19, P232
   López-Castillo Christian A., 2005, Rev. salud pública, V7, P180
   LOVELACE JK, 1978, TROP GEOGR MED, V30, P295
   Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X
   Rubinsky-Elefant G, 2008, AM J TROP MED HYG, V79, P93, DOI 10.4269/ajtmh.2008.79.93
   Sobral CA, 2005, AM J TROP MED HYG, V72, P37, DOI 10.4269/ajtmh.2005.72.37
   SOUZA EA, 2007, CAD SAUDE PUBLICA, V23, P427, DOI DOI 10.1590/S0102-311X2007000200019
   Spalding SM, 2005, REV SOC BRAS MED TRO, V38, P173, DOI 10.1590/S0037-86822005000200009
   Sukthana Y, 2006, TRENDS PARASITOL, V22, P137, DOI 10.1016/j.pt.2006.01.007
   Sukthana Yaowalark, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P733
   Taylor MRH, 1997, ARCH DIS CHILD, V77, P406, DOI 10.1136/adc.77.5.406
   Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7
   ULMANEN I, 1975, SCAND J INFECT DIS, V7, P67, DOI 10.3109/inf.1975.7.issue-1.12
   VENKATESAN P, 1993, PARASITOL TODAY, V9, P228, DOI 10.1016/0169-4758(93)90020-G
   ZUBER PLF, 1995, AM J EPIDEMIOL, V141, P659, DOI 10.1093/oxfordjournals.aje.a117482
NR 39
TC 11
Z9 12
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD JUL
PY 2009
VL 81
IS 1
BP 171
EP 176
DI 10.4269/ajtmh.2009.81.171
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 464SI
UT WOS:000267526500029
PM 19556584
OA Bronze
DA 2020-12-08
ER

PT J
AU da Silva, NS
   Muniz, VD
AF da Silva, Natal Santos
   Muniz, Vitor Dantas
TI Epidemiology of American tegumentary leishmaniasis in the State of Acre,
   Brazilian Amazon
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Leishmaniasis; Residence Characteristics; Amazonian Ecosystem
ID CUTANEOUS LEISHMANIASIS; DIAGNOSIS; AREA; PCR
AB This was a descriptive statistical study of 8,516 cases of American tegumentary leishmaniasis in the State of Acre, Brazil, from 2001 to 2006 (second period), comparing the results to a previous publication with data from the same State for 1992 to 1997 (first period). Prevalence in the State more than doubled (55.7/10,000 inhabitants from 1992 to 1997 and 128.5/10,000 inhabitants from 2001 to 2006). Males predominated (68.8%, n = 5,860) in the second period. Mean age in the second period was 26.3 years, slightly lower than in the first. Individuals with low schooling were more affected by the disease. The other variables were area of residence, occupation, diagnostic criterion, clinical form, treatment, relapse, time before seeking treatment, and evolution. In conclusion, American tegumentary leishmaniasis epidemiological indicators worsened in the State between the two periods.
C1 [da Silva, Natal Santos] Univ Sao Paulo, Dept Parasitol, Inst Ciencias Biomed, BR-05508900 Sao Paulo, Brazil.
   [Muniz, Vitor Dantas] Univ Fed Acre, Ctr Ciencias Saude Desporto, Rio Branco, Brazil.
RP da Silva, NS (corresponding author), Univ Sao Paulo, Dept Parasitol, Inst Ciencias Biomed, Rua Prof Lineu Prestes 1374, BR-05508900 Sao Paulo, Brazil.
EM natalss@gmail.com
RI da Silva, Natal Santos/E-9579-2015
OI da Silva, Natal Santos/0000-0002-0856-1748
CR Ampuero J, 2006, REV SOC BRAS MED TRO, V39, P22, DOI 10.1590/S0037-86822006000100004
   [Anonymous], 2004, Rev. Saúde Pública, V38, P331, DOI 10.1590/S0034-89102004000200027
   Aparicio C, 2004, REV SAUDE PUBL, V38, P511, DOI 10.1590/S0034-89102004000400005
   Barros MBD, 2005, ACTA TROP, V93, P41, DOI 10.1016/j.actatropica.2004.09.004
   BORGES VC, 2002, REV SOC BRAS MED TRO, V36, P249
   da Costa SM, 2007, MEM I OSWALDO CRUZ, V102, P149, DOI 10.1590/S0074-02762007005000016
   Castro Edilene Alcântara de, 2002, Rev. Soc. Bras. Med. Trop., V35, P445, DOI 10.1590/S0037-86822002000500004
   Guerra Jorge Augusto de Oliveira, 2003, Rev. Soc. Bras. Med. Trop., V36, P587, DOI 10.1590/S0037-86822003000500008
   Follador I, 1999, Rev Soc Bras Med Trop, V32, P497, DOI 10.1590/S0037-86821999000500005
   Garcia AL, 2007, T ROY SOC TROP MED H, V101, P1208, DOI 10.1016/j.trstmh.2007.09.002
   Gontijo Bernardo, 2003, Rev. Soc. Bras. Med. Trop., V36, P71, DOI 10.1590/S0037-86822003000100011
   Guerra Jorge Augusto de Oliveira, 2006, Cad. Saúde Pública, V22, P2319, DOI 10.1590/S0102-311X2006001100006
   *I BRAS GEOGR EST, 1997, AN EST ACR
   LIMA MVN, 2008, CAD SAUDE PUBLICA, V23, P2938
   Martins Luzenice Macedo, 2004, Cad. Saúde Pública, V20, P735, DOI 10.1590/S0102-311X2004000300010
   Ministerio da Saude. Secretaria de Vigilncia em Saude, 2007, MAN VIG LEISHM TEG A
   Lessa Marcus Miranda, 2007, Rev. Bras. Otorrinolaringol., V73, P843, DOI 10.1016/S1808-8694(15)31181-2
   Monteiro WM, 2008, CAD SAUDE PUBLICA, V24, P1291, DOI 10.1590/S0102-311X2008000600010
   Moreira Rosilene da Conceição R., 2002, Cad. Saúde Pública, V18, P187, DOI 10.1590/S0102-311X2002000100019
   Nunes Adriana Guimarães, 2006, Cad. Saúde Pública, V22, P1343, DOI 10.1590/S0102-311X2006000600023
   Oliveira JGS, 2005, ACTA TROP, V94, P55, DOI 10.1016/j.actatropica.2004.12.003
   Passos V M, 2001, Rev Soc Bras Med Trop, V34, P5, DOI 10.1590/S0037-86822001000100002
   Passos VMA, 2000, B WORLD HEALTH ORGAN, V78, P968
   Rhajaoui M, 2007, EMERG INFECT DIS, V13, P1358, DOI 10.3201/eid1309.060946
   Rodrigues EHG, 2002, J CLIN MICROBIOL, V40, P3572, DOI 10.1128/JCM.40.10.3572-3576.2002
   Santiago CB, 2000, J APPL ICHTHYOL, V16, P8, DOI 10.1046/j.1439-0426.2000.00137.x
   SHAW JJ, 1975, T ROY SOC TROP MED H, V69, P323, DOI 10.1016/0035-9203(75)90127-3
   Silva Lúcia Mensato Rebello da, 2007, An. Bras. Dermatol., V82, P515, DOI 10.1590/S0365-05962007000600003
   SILVA NS, 1999, REV SAUDE PUBL, V33, P554, DOI DOI 10.1590/S0034-89101999000600006
   da Silva ACT, 2006, TROP MED INT HEALTH, V11, P1388, DOI 10.1111/j.1365-3156.2006.01695.x
   Vera L A, 2001, Rev Soc Bras Med Trop, V34, P233, DOI 10.1590/S0037-86822001000300001
   Ximenes MDFFDM, 2007, NEOTROP ENTOMOL, V36, P128, DOI 10.1590/S1519-566X2007000100016
NR 32
TC 12
Z9 14
U1 0
U2 3
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD JUN
PY 2009
VL 25
IS 6
BP 1325
EP 1336
DI 10.1590/S0102-311X2009000600015
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 455RX
UT WOS:000266783400015
PM 19503963
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Terzian, ACB
   Bronzoni, RVD
   Drumond, BP
   da Silva-Nunes, M
   da Silva, NS
   Ferreira, MU
   Speranca, MA
   Nogueira, ML
AF Terzian, Ana Carolina Bernardes
   de Moraes Bronzoni, Roberta Vieira
   Drumond, Betania Paiva
   da Silva-Nunes, Monica
   da Silva, Natal Santos
   Ferreira, Marcelo Urbano
   Speranca, Marcia Aparecida
   Nogueira, Mauricio Lacerda
TI Sporadic Oropouche Virus Infection, Acre, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID NESTED-PCR
C1 [Nogueira, Mauricio Lacerda] FAMERP, Dept Doencas Infecciosas & Parasitarias, Lab Pesquisas Virol, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
   [Terzian, Ana Carolina Bernardes] IBILCE, Sao Jose Do Rio Preto, Brazil.
   [Drumond, Betania Paiva] Univ Estudal Montes Claros, Montes Claros, Brazil.
   [da Silva-Nunes, Monica; da Silva, Natal Santos; Ferreira, Marcelo Urbano] Univ Sao Paulo, Inst Ciencias Biol, Sao Paulo, Brazil.
   [Speranca, Marcia Aparecida] Fac Med Marilia, Sao Paulo, Brazil.
RP Nogueira, ML (corresponding author), FAMERP, Dept Doencas Infecciosas & Parasitarias, Lab Pesquisas Virol, Av Brigadeiro Faria Lima 5416, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
EM mnogueira@tamerp.br
RI Bronzoni, Roberta/J-8917-2012; Ferreira, Marcelo U/G-8289-2011;
   Speranca, Marcia Aparecida/D-2310-2012; Nogueira, Mauricio
   L/B-7599-2012; da Silva, Natal Santos/Y-1913-2019; da Silva-Nunes,
   Monica/A-1885-2008; da Silva, Natal Santos/E-9579-2015
OI Ferreira, Marcelo U/0000-0002-5293-9090; Speranca, Marcia
   Aparecida/0000-0002-1178-3747; Nogueira, Mauricio L/0000-0003-1102-2419;
   da Silva, Natal Santos/0000-0002-0856-1748; da Silva, Natal
   Santos/0000-0002-0856-1748
CR ANDERSON CR, 1961, AM J TROP MED HYG, V10, P574, DOI 10.4269/ajtmh.1961.10.574
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Azevedo RDD, 2007, EMERG INFECT DIS, V13, P912
   Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150
   Moreli ML, 2002, J MED VIROL, V66, P139, DOI 10.1002/jmv.2122
   Nunes WRT, 2005, EMERG INFECT DIS, V11, P1610, DOI 10.3201/eid1110.050464
   Pinheiro F.P., 2004, TXB PEDIAT INFECT DI, P2418
   Saeed MF, 2000, J GEN VIROL, V81, P743, DOI 10.1099/0022-1317-81-3-743
   SHOPE ROBERT E., 1963, AN MICROBIOL, V11, P167
   Silva-Nunes Mônica da, 2006, Cad. Saúde Pública, V22, P1325, DOI 10.1590/S0102-311X2006000600021
NR 10
TC 18
Z9 18
U1 0
U2 1
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD FEB
PY 2009
VL 15
IS 2
BP 348
EP 350
DI 10.3201/eid1502.080401
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 405NE
UT WOS:000263230700040
PM 19193295
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU da Silva-Nunes, M
   de Souza, VAF
   Pannuti, CS
   Speranca, MA
   Terzian, ACB
   Nogueira, ML
   Yamamura, AMY
   Freire, MS
   da Silva, NS
   Malafronte, RS
   Muniz, PT
   Vasconcelos, HB
   da Silva, EVP
   Vasconcelos, PFC
   Ferreira, MU
AF da Silva-Nunes, Monica
   de Souza, Vanda A. F.
   Pannuti, Claudio S.
   Speranca, Marcia A.
   Terzian, Ana Carolina B.
   Nogueira, Mauricio L.
   Yamamura, Anna M. Y.
   Freire, Marcos S.
   da Silva, Natal S.
   Malafronte, Rosely S.
   Muniz, Pascoal T.
   Vasconcelos, Helena B.
   da Silva, Eliana V. P.
   Vasconcelos, Pedro F. C.
   Ferreira, Marcelo U.
TI Risk factors for dengue virus infection in rural Amazonia:
   Population-based cross-sectional surveys
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID PRIMARY-SCHOOL CHILDREN; HEMORRHAGIC-FEVER; KAMPHAENG PHET; BRAZIL;
   EPIDEMIOLOGY; ANTIBODIES; THAILAND; SEROPREVALENCE; SURVEILLANCE; INDIA
AB A comparison of dengue virus (DENV) antibody levels in paired serum samples collected from predominantly DENV-naive residents in an agricultural settlement in Brazilian Amazonia (baseline seroprevalence, 18.3%) showed a seroconversion rate of 3.67 episodes/100 person-years at risk during 12 months of follow-up. Multivariate analysis identified male sex, poverty, and migration from extra-Amazonian states as significant predictors of baseline DENY seropositivity, whereas male sex, a history of clinical diagnosis of dengue fever, and travel to an urban area predicted subsequent seroconversion. The laboratory surveillance of acute febrile illnesses implemented at the study site and in a nearby town between 2004 and 2006 confirmed 11. DENV infections among 102 episodes studied with DENV IgM detection, reverse transcriptase-polymerise chain reaction, and virus isolation; DENV-3 was isolated. Because DENV exposure is associated with migration or travel, personal protection measures when visiting high-risk urban areas may reduce the incidence of DENV infection in this rural population.
C1 [da Silva-Nunes, Monica] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, BR-05508900 Sao Paulo, Brazil.
   Inst Trop Med, Virol Lab, BR-05403000 Sao Paulo, SP, Brazil.
   Marilia Med Sch, Mol Biol Lab, BR-17519030 Marilia, SP, Brazil.
   Fac Med Sao Jose do Rio Preto, Virol Lab, BR-15090000 Sao Jose Do Rio Preto, Brazil.
   Fundacao Oswaldo Cruz, Inst Technol Immunobiol, BR-21040900 Rio De Janeiro, RJ, Brazil.
   Inst Trop Med, Lab Protozool, BR-05403000 Sao Paulo, SP, Brazil.
   Univ Fed Acre, Dept Hlth Sci, BR-69915900 Rio Branco, AC, Brazil.
   Evandro Chagas Inst, Lab Arbovirol & Hemorrhag Fevers, BR-66093020 Belem, Para, Brazil.
RP da Silva-Nunes, M (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Av Prof Lineu Prestes 1374, BR-05508900 Sao Paulo, Brazil.
EM msnunes1@yahoo.com.br
RI da Silva-Nunes, Monica/A-1885-2008; Nogueira, Mauricio L/B-7599-2012;
   Pannuti, Claudio/B-7649-2012; Malafronte, Rosely/C-3138-2013;
   Vasconcelos, Pedro/AAH-3142-2019; Ferreira, Marcelo U/G-8289-2011; da
   Silva, Natal Santos/E-9579-2015; Speranca, Marcia Aparecida/D-2310-2012;
   da Silva, Natal Santos/Y-1913-2019
OI Nogueira, Mauricio L/0000-0003-1102-2419; Ferreira, Marcelo
   U/0000-0002-5293-9090; da Silva, Natal Santos/0000-0002-0856-1748;
   Speranca, Marcia Aparecida/0000-0002-1178-3747; da Silva, Natal
   Santos/0000-0002-0856-1748
FU Ministry of HealthMinistry of Health - Turkey [50148920037]; Fundacao de
   Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [04/00373-2]; FAPESPFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de
   Desenvolvimento Cientffico a Tecnologico (CNPq), BrazilNational Council
   for Scientific and Technological Development (CNPq)
FX The authors thank the inhabitants of Ramal do Granada for enthusiastic
   participation in the study; SebastiAoBocalom Rodrigues (Mayor of
   Acrelandia), Damaris de Oliveira, and Nesio M. Carvalho (Municipal
   Government of Acrelandia) for logistic support: Adamilson L. de Souza,
   Camila Juncansen, Carlos E. Cavasim, and Kezia K. G. Scopel for help
   with fieldwork; Estefano A. de Souza and Bruna A. Luz for data
   management; Cassiano P. Nunes for artwork: and Tatiana Havryliuk for
   reviewing the manuscript.; Financial support: This study was supported
   by grants from the Ministry of Health of Brazil (50148920037) and the
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP,
   04/00373-2). MA.S.-N. is supported by a PhD scholarship from FAPESP.
   C.S.P., N.S.d.S., P.F.C.V., and M.U.F. receive scholarships from the
   Conselho Nacional de Desenvolvimento Cientffico a Tecnologico (CNPq),
   Brazil. Focus Diagnostics (Cypress, CA) kindly donated ELISA kits for
   DENV and WNV antibody detection used in this study.
CR [Anonymous], 1994, DENG DENG HEM FEV AM
   Aquino VH, 2006, AM J TROP MED HYG, V75, P710, DOI 10.4269/ajtmh.2006.75.710
   Baleotti FG, 2003, MEM I OSWALDO CRUZ, V98, P379, DOI 10.1590/S0074-02762003000300015
   Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Chareonsook O, 1999, EPIDEMIOL INFECT, V122, P161, DOI 10.1017/S0950268898001617
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
   Cunha RV, 1999, T ROY SOC TROP MED H, V93, P247, DOI 10.1016/S0035-9203(99)90008-1
   de Souza VAUF, 2004, J CLIN MICROBIOL, V42, P1782, DOI 10.1128/JCM.42.4.1782-1784.2004
   DIETZ VJ, 1990, AM J EPIDEMIOL, V131, P693
   Endy TP, 2002, AM J EPIDEMIOL, V156, P52, DOI 10.1093/aje/kwf006
   Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005
   Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003
   Freire MS, 2005, VACCINE, V23, P2501, DOI 10.1016/j.vaccine.2004.10.035
   Galler R, 2005, BRAZ J MED BIOL RES, V38, P1835, DOI 10.1590/S0100-879X2005001200012
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Guha P, 2005, INT J GEOM METHODS M, V2, P1, DOI 10.1142/S0219887805000429
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311
   Hayes CG, 1996, AM J TROP MED HYG, V55, P459, DOI 10.4269/ajtmh.1996.55.459
   KAPLAN JE, 1983, AM J EPIDEMIOL, V117, P335, DOI 10.1093/oxfordjournals.aje.a113546
   KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809
   Kumar Avdhesh, 2001, Journal of Communicable Diseases, V33, P274
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lian CW, 2006, TROP BIOMED, V23, P85
   *MIN HLTH BRAZ, 2002, PROGR NAC CONTR DENG
   Nunes-Araujo FRF, 2003, ANN TROP MED PARASIT, V97, P415, DOI 10.1179/000349803235002263
   Regato M, 2008, VIRUS RES, V132, P197, DOI 10.1016/j.virusres.2007.10.012
   Reiskind MH, 2001, TROP MED INT HEALTH, V6, P212, DOI 10.1046/j.1365-3156.2001.00703.x
   Rodrigues Marisa B. P., 2005, J. Pediatr. (Rio J.), V81, P209, DOI 10.1590/S0021-75572005000400007
   Shope RE, 1979, DIAGNOSTIC PROCEDURE, P767
   Silva-Nunes Mônica da, 2006, Cad. Saúde Pública, V22, P1325, DOI 10.1590/S0102-311X2006000600021
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   Stefano I, 1999, VACCINE, V17, P1042, DOI 10.1016/S0264-410X(98)00320-X
   Strickman D, 2000, AM J TROP MED HYG, V63, P27, DOI 10.4269/ajtmh.2000.63.27
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Tauil PL, 2006, REV SOC BRAS MED TRO, V39, P275, DOI 10.1590/S0037-86822006000300010
   Tavares-Neto José, 2004, Rev. Soc. Bras. Med. Trop., V37, P1, DOI 10.1590/S0037-86822004000100001
   Tewari SC, 2004, TROP MED INT HEALTH, V9, P499, DOI 10.1111/j.1365-3156.2004.01103.x
   Thai KTD, 2005, TROP MED INT HEALTH, V10, P379, DOI 10.1111/j.1365-3156.2005.01388.x
   Torralba JM, 2007, ADV MATER RES-SWITZ, V23, P1, DOI 10.4028/www.scientific.net/AMR.23.1
   TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P181, DOI 10.1016/0035-9203(85)90329-3
   Vanwambeke Sophie O, 2006, Int J Health Geogr, V5, P5, DOI 10.1186/1476-072X-5-5
   Vasconcelos P F, 1999, Rev Soc Bras Med Trop, V32, P171
NR 43
TC 25
Z9 26
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD OCT
PY 2008
VL 79
IS 4
BP 485
EP 494
DI 10.4269/ajtmh.2008.79.485
PG 10
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 357PG
UT WOS:000259858000004
PM 18840734
OA Bronze
DA 2020-12-08
ER

PT J
AU da Silva-Nunes, M
   Codeco, CT
   Malafronte, RS
   da Silva, NS
   Juncansen, C
   Muniz, PT
   Ferreira, MU
AF da Silva-Nunes, Monica
   Codeco, Claudia T.
   Malafronte, Rosely S.
   da Silva, Natal S.
   Juncansen, Camila
   Muniz, Pascoal T.
   Ferreira, Marcelo U.
TI Malaria on the Amazonian frontier: Transmission dynamics, risk factors,
   spatial distribution, and prospects for control
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID PLASMODIUM-VIVAX; PERUVIAN AMAZON; FALCIPARUM-MALARIA; RURAL AMAZONIANS;
   HIGH PREVALENCE; INFECTIONS; INTERVENTIONS; POPULATION; ANTIBODIES;
   COMMUNITY
AB Little follow-up data on malaria transmission in communities originating from frontier settlements in Amazonia are available. Here we describe a cohort study in a frontier settlement in Acre, Brazil, where 509 subjects contributed 489.7 person-years of follow-up. The association between malaria morbidity during the follow-up and individual, household, and spatial covariates was explored with mixed-effects logistic regression models and spatial analysis. Incidence rates for Plasmodium vivax and Plasmodium falciparum malaria were 30.0/100 and 16.3/100 person-years at risk, respectively. Malaria morbidity was strongly associated with land clearing and farming, and decreased after five years of residence in the area, suggesting that clinical immunity develops among subjects exposed to low malaria endemicity. Significant spatial clustering of malaria was observed in the areas of most recent occupation, indicating that the continuous influx of nonimmune settlers to forest-fringe areas perpetuates the cycle of environmental change and colonization that favors malaria transmission in rural Amazonia.
C1 [da Silva-Nunes, Monica] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, BR-05508900 Sao Paulo, Brazil.
   Fundacao Oswaldo Cruz, Program Sci Computat, BR-21045900 Rio De Janeiro, Brazil.
   Inst Trop Med, Lab Protozool, BR-05403000 Sao Paulo, Brazil.
   Univ Fed Acre, Dept Hlth Sci, BR-69915000 Rio Branco, Acre, Brazil.
RP da Silva-Nunes, M (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Av Prof Lineu Prestes 1374, BR-05508900 Sao Paulo, Brazil.
EM msnunes1@yahoo.com.br
RI da Silva-Nunes, Monica/A-1885-2008; da Silva, Natal Santos/E-9579-2015;
   Malafronte, Rosely/C-3138-2013; Ferreira, Marcelo U/G-8289-2011; da
   Silva, Natal Santos/Y-1913-2019
OI da Silva, Natal Santos/0000-0002-0856-1748; Ferreira, Marcelo
   U/0000-0002-5293-9090; da Silva, Natal Santos/0000-0002-0856-1748
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [470067/2004-7]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [03/09719-6, 05/51988-0]
FX CNPq (470067/2004-7) and FAPESP (03/09719-6 and 05/51988-0) to M.U.F.;
   scholarships from FAPESP (MAS.N. and C.J.), and CNPq (N.S.dS. and
   M.U.F.) are also acknowledged.
CR Alves FP, 2002, AM J TROP MED HYG, V66, P641, DOI 10.4269/ajtmh.2002.66.641
   Bastos MS, 2007, CLIN VACCINE IMMUNOL, V14, P1249, DOI 10.1128/CVI.00243-07
   Bates D, 2008, IME4 PACKAGE
   Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27
   Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401
   Cavasini M T, 2000, Rev Soc Bras Med Trop, V33, P489, DOI 10.1590/S0037-86822000000500011
   COOK RD, 1984, RESIDUALS INFLUENCE
   da Silva-Nunes M, 2007, MEM I OSWALDO CRUZ, V102, P341, DOI 10.1590/S0074-02762007005000051
   de Castro MC, 2007, HEALTH PLACE, V13, P368, DOI 10.1016/j.healthplace.2006.03.006
   de Castro MC, 2006, P NATL ACAD SCI USA, V103, P2452, DOI 10.1073/pnas.0510576103
   Duarte EC, 2004, AM J TROP MED HYG, V70, P229, DOI 10.4269/ajtmh.2004.70.229
   Erhart A, 2004, AM J TROP MED HYG, V70, P110, DOI 10.4269/ajtmh.2004.70.110
   Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685
   Ferreira MU, 2007, AM J PUBLIC HEALTH, V97, P237, DOI 10.2105/AJPH.2005.078121
   Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003
   FOX J, 1997, APPL REGRESSION LINE
   *FUNC NAC SAUD, 2001, DIAGN TRAT MAL
   Kimura Masatsugu, 1997, Parasitology International, V46, P91, DOI 10.1016/S1383-5769(97)00013-5
   KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809
   Loiola Carlos Catão Prates, 2002, Rev Panam Salud Publica, V11, P235, DOI 10.1590/S1020-49892002000400005
   MARCELO L, 1994, AM J TROP MED HYG, V51, P16, DOI 10.4269/ajtmh.1994.51.16
   MARQUES AC, 1987, PARASITOL TODAY, V3, P166, DOI 10.1016/0169-4758(87)90170-0
   *MIN HLTH BRAZ, NAT PROGR MAL PREV C
   Najera J. A., 2001, Parassitologia (Rome), V43, P1
   Norris DE, 2004, ECOHEALTH, V1, P19, DOI DOI 10.1007/s10393-004-0008-7
   R Development Core Team, 2007, R FDN STAT COMP
   Roshanravan B, 2003, AM J TROP MED HYG, V69, P45, DOI 10.4269/ajtmh.2003.69.45
   Sakamoto Y., 1986, AKAIKE INFORM CRITER
   SaTScan, SOFTW SPAT TEMP SPAC
   Sawyer D. R., 1988, FRONTIER MALARIA AMA
   Scopel KKG, 2007, AM J TROP MED HYG, V76, P1084, DOI 10.4269/ajtmh.2007.76.1084
   Scopel KKG, 2004, ACTA TROP, V90, P61, DOI 10.1016/j.actatropica.2003.11.002
   SHARMA VP, 1991, P INF CONS M WHO MRC
   Silva-Nunes Mônica da, 2006, Cad. Saúde Pública, V22, P1325, DOI 10.1590/S0102-311X2006000600021
   Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3
   Win TT, 2002, TROP MED INT HEALTH, V7, P231, DOI 10.1046/j.1365-3156.2002.00857.x
   Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980
NR 37
TC 66
Z9 69
U1 0
U2 5
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD OCT
PY 2008
VL 79
IS 4
BP 624
EP 635
DI 10.4269/ajtmh.2008.79.624
PG 12
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 357PG
UT WOS:000259858000025
PM 18840755
OA Bronze, Green Published
DA 2020-12-08
ER

PT J
AU Ferreira, MU
   Karunaweera, ND
   da Silva-Nunes, M
   da Silva, NS
   Wirth, DF
   Hartl, DL
AF Ferreira, Marcelo U.
   Karunaweera, Nadira D.
   da Silva-Nunes, Monica
   da Silva, Natal S.
   Wirth, Dyann F.
   Hartl, Daniel L.
TI Population structure and transmission dynamics of plasmodium vivax in
   rural amazonia
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
ID MEROZOITE SURFACE PROTEIN-1; SEQUENCE DIVERSITY; FALCIPARUM POPULATIONS;
   MICROSATELLITE MARKERS; ANTIBODY RECOGNITION; MOLECULAR ANALYSIS;
   MALARIA; VACCINE; STRAINS; MSP-2
AB Understanding the genetic structure of malaria parasites is essential to predict how fast some phenotypes of interest originate and spread in populations. In the present study, we used highly polymorphic microsatellite markers to analyze 74 Plasmodium vivax isolates, which we collected in cross-sectional and longitudinal surveys performed in an area of low malaria endemicity in Brazilian Amazonia, and to explore the transmission dynamics of genetically diverse haplotypes or strains. P. vivax populations are more diverse and more frequently comprise multiple-clone infections than do sympatric Plasmodium falciparum isolates, but these features paradoxically coexist with high levels of inbreeding, leading to significant multilocus linkage disequilibrium. Moreover, the high rates of microsatellite haplotype replacement that we found during 15 months of follow-up most likely do not result from strong diversifying selection. We conclude that the small-area genetic diversity in P. vivax populations under low-level transmission is not severely constrained by the low rates of effective meiotic recombination, with clear public health implications.
C1 Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.
   Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.
   Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil.
   Univ Colombo, Fac Med, Dept Parasitol, Colombo, Sri Lanka.
RP Hartl, DL (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, 16 Divin Ave, Cambridge, MA 02138 USA.
EM dhartl@oeb.harvard.edu
RI da Silva-Nunes, Monica/A-1885-2008; da Silva, Natal Santos/Y-1913-2019;
   da Silva, Natal Santos/E-9579-2015; Ferreira, Marcelo U/G-8289-2011
OI da Silva, Natal Santos/0000-0002-0856-1748; da Silva, Natal
   Santos/0000-0002-0856-1748; Ferreira, Marcelo U/0000-0002-5293-9090;
   Karunaweera, Nadira/0000-0003-3985-1817
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM061351,
   R01GM061351, R01GM061351, R01GM061351, R01GM061351, R01GM061351,
   R01GM061351, R01GM061351, R01GM061351] Funding Source: NIH RePORTER;
   NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01 GM061351] Funding Source: Medline
CR Anderson Tim J. C., 2004, Current Drug Targets - Infectious Disorders, V4, P65, DOI 10.2174/1568005043480943
   Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247
   Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552
   Carlton J, 2003, TRENDS PARASITOL, V19, P227, DOI 10.1016/S1471-4922(03)00066-7
   Craig AA, 1996, J INFECT DIS, V174, P373, DOI 10.1093/infdis/174.2.373
   Cui LW, 2003, TRENDS PARASITOL, V19, P220, DOI 10.1016/S1471-4922(03)00085-0
   Da Silveira LA, 1999, INFECT IMMUN, V67, P5906, DOI 10.1128/IAI.67.11.5906-5916.1999
   Escalante AA, 2004, TRENDS PARASITOL, V20, P388, DOI 10.1016/j.pt.2004.06.002
   Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004
   Ferreira MU, 2003, GENE, V304, P65, DOI 10.1016/S0378-1119(02)01180-0
   FORSYTH KP, 1988, PHILOS T ROY SOC B, V321, P485, DOI 10.1098/rstb.1988.0104
   Gomez JC, 2003, AM J TROP MED HYG, V69, P377, DOI 10.4269/ajtmh.2003.69.377
   Guerra CA, 2006, TRENDS PARASITOL, V22, P353, DOI 10.1016/j.pt.2006.06.006
   GUPTA S, 1994, P ROY SOC B-BIOL SCI, V256, P231, DOI 10.1098/rspb.1994.0075
   Hastings IM, 1997, PARASITOL TODAY, V13, P375, DOI 10.1016/S0169-4758(97)01110-1
   Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847
   Hoffmann EHE, 2006, GENE, V376, P224, DOI 10.1016/j.gene.2006.03.011
   HUDSON RR, 1994, J EVOLUTION BIOL, V7, P535, DOI 10.1046/j.1420-9101.1994.7050535.x
   *I GEN RES, PLASM VIV GEN PROJ
   Imwong M, 2006, MOL BIOL EVOL, V23, P1016, DOI 10.1093/molbev/msj116
   Joy D, 2004, MALARIA PARASITES: GENOMES AND MOLECULAR BIOLOGY, P167
   Karunaweera ND, 2007, MOL ECOL NOTES, V7, P172, DOI 10.1111/j.1471-8286.2006.01534.x
   Kimura Masatsugu, 1997, Parasitology International, V46, P91, DOI 10.1016/S1383-5769(97)00013-5
   Kirchgatter K, 1998, J INFECT DIS, V177, P511, DOI 10.1086/517389
   Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642
   Laserson KF, 1999, AM J TROP MED HYG, V60, P767, DOI 10.4269/ajtmh.1999.60.767
   Leclerc MC, 2004, P NATL ACAD SCI USA, V101, P14455, DOI 10.1073/pnas.0405186101
   Loiola Carlos Catão Prates, 2002, Rev Panam Salud Publica, V11, P235, DOI 10.1590/S1020-49892002000400005
   Machado RLD, 2004, J INFECT DIS, V190, P1547, DOI 10.1086/424601
   MAYNARDSMITH J, 1993, P NATIONAL ACADEMY S, V90, P4384
   McKenzie FE, 2001, EVOLUTION, V55, P1299, DOI 10.1111/j.0014-3820.2001.tb00652.x
   Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97
   *MIN SAUD FUND NAC, 2001, MAN ANT THER
   Schlotterer C., 1998, MOL GENETIC ANAL POP, P237, DOI DOI 10.1038/NPG.ELS.0000840
   Silva NS, 2000, ANN TROP MED PARASIT, V94, P675, DOI 10.1080/00034983.2000.11813591
   Silva-Nunes Mônica da, 2006, Cad. Saúde Pública, V22, P1325, DOI 10.1590/S0102-311X2006000600021
   Tonon AP, 2004, EXP PARASITOL, V108, P114, DOI 10.1016/j.exppara.2004.08.001
   TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P181, DOI 10.1016/0035-9203(85)90329-3
   TRAVIS J, 1990, PHILOS T R SOC B, V330, P253, DOI 10.1098/rstb.1990.0196
   Urdaneta L, 2001, P NATL ACAD SCI USA, V98, P6725, DOI 10.1073/pnas.111144998
   Win TT, 2002, TROP MED INT HEALTH, V7, P231, DOI 10.1046/j.1365-3156.2002.00857.x
   Zilversmit M, 2005, MOLECULAR APPROACHES TO MALARIA, P95
   PUBMLST LIAN 3 5
   ARLEQUIN 3 1
   POPTOOLS
NR 45
TC 110
Z9 113
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD APR 15
PY 2007
VL 195
IS 8
BP 1218
EP 1226
DI 10.1086/512685
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 153AW
UT WOS:000245405100021
PM 17357061
OA Bronze
DA 2020-12-08
ER

PT J
AU Silva, NS
   Silveira, LA
   Machado, RLD
   Povoa, MM
   Ferreira, MU
AF Silva, NS
   Silveira, LA
   Machado, RLD
   Povoa, MM
   Ferreira, MU
TI Temporal and spatial distribution of the variants of merozoite surface
   protein-1 (MSP-1) in Plasmodium falciparum populations in Brazil
SO ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY
LA English
DT Article
ID ALLELIC DIVERSITY; SOUTHERN VIETNAM; MALARIA; EPIDEMIOLOGY; VACCINE;
   RECOMBINATION; ANTIBODIES; ANTIGENS; PARASITE; AMAZON
AB The polymorphic, merozoite surface protein-1 (MSP-1) of Plasmodium falciparum, an antigen of the parasite's asexual blood-stages, is a major malaria vaccine candidate. Nucleotide sequences of each variable domain or block of this antigen may be grouped into one of three possible allelic types (K1, MAD20 and RO33), and 24 major types of the msp-1 gene may be defined, as unique combinations of allelic types in these variable blocks. Isolates collected from the Brazilian Amazon, over a period of 14 years, have now been investigated, by PCR-based typing of the msp-1 gene. Thirteen of the 24 possible gene-types were identified, and 336 P. falciparum clones were fully typed among 239 isolates. Most parasites (87%) belonged to one of the seven most frequent gene-types. Marked temporal variation in the distribution of msp-1 variants was found when comparing parasites sampled in the same sites at intervals of at least 5 years. Spatial variations were also found when comparing parasites from both neighbouring and distant sites within the Amazon Basin. The between-population variance in the frequencies of msp-1 allelic types found in Brazil, as estimated by Wright's F-ST statistic, is of similar magnitude to that found in previous world-wide comparisons. The potential implications of these findings for the development of an MSP-1 based, multivalent malaria vaccine are discussed.
C1 Fac Med & Enfermagem de Sao Jose do Rio Preto, Dept Doencas Infecc & Parasitarias, Mol Parasitol Lab, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
   Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil.
   Univ Fed Goias, Inst Patol Trop & Saude Publ, Dept Microbiol Imunjol Parasitol & Patol Geral, Goiania, Go, Brazil.
   Fdn Nacl Saude, Inst Evandro Chagas, Serv Parasitol, Programa Malaria, Belem, Para, Brazil.
RP Ferreira, MU (corresponding author), Fac Med & Enfermagem de Sao Jose do Rio Preto, Dept Doencas Infecc & Parasitarias, Mol Parasitol Lab, Av Brigadeiro Faria Lima 5416, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
RI Ferreira, Marcelo U/G-8289-2011; da Silva, Natal Santos/E-9579-2015; da
   Silva, Natal Santos/Y-1913-2019; Povoa, Marinete Marins/C-7039-2017;
   Machado, Ricardo Luiz Dantas Dantas/P-1288-2014
OI Ferreira, Marcelo U/0000-0002-5293-9090; da Silva, Natal
   Santos/0000-0002-0856-1748; da Silva, Natal Santos/0000-0002-0856-1748;
   Povoa, Marinete Marins/0000-0003-3517-2227; Machado, Ricardo Luiz Dantas
   Dantas/0000-0002-8955-3204
CR BABIKER HA, 1995, AM J TROP MED HYG, V53, P7, DOI 10.4269/ajtmh.1995.53.7
   Bjorkman A, 1998, PARASITOL TODAY, V14, P85, DOI 10.1016/S0169-4758(97)01201-5
   Camargo LMA, 1996, AM J TROP MED HYG, V55, P32, DOI 10.4269/ajtmh.1996.55.32
   Cavanagh DR, 1998, J IMMUNOL, V161, P347
   Conover W, 1999, PRACTICAL NONPARAMET
   CONWAY DJ, 1992, INFECT IMMUN, V60, P1122, DOI 10.1128/IAI.60.3.1122-1127.1992
   Conway DJ, 1997, PARASITOL TODAY, V13, P26, DOI 10.1016/S0169-4758(96)10077-6
   Conway DJ, 1999, P NATL ACAD SCI USA, V96, P4506, DOI 10.1073/pnas.96.8.4506
   Drakeley CJ, 1996, MOL BIOCHEM PARASIT, V81, P253, DOI 10.1016/0166-6851(96)02718-1
   Ferreira MU, 1998, J EUKARYOT MICROBIOL, V45, P131, DOI 10.1111/j.1550-7408.1998.tb05080.x
   Ferreira MU, 1998, AM J TROP MED HYG, V59, P474, DOI 10.4269/ajtmh.1998.59.474
   Ferreira MU, 1998, J PARASITOL, V84, P1286, DOI 10.2307/3284693
   FORSYTH KP, 1988, PHILOS T ROY SOC B, V321, P485, DOI 10.1098/rstb.1988.0104
   Good MF, 1998, ANNU REV IMMUNOL, V16, P57, DOI 10.1146/annurev.immunol.16.1.57
   Guevara-Patino JA, 1997, J EXP MED, V186, P1689, DOI 10.1084/jem.186.10.1689
   Holder AA, 1996, PARASITOL TODAY, V12, P173, DOI 10.1016/0169-4758(96)20009-2
   Holder Anthony A., 1996, P77
   Kaneko O, 1997, EXP PARASITOL, V86, P45, DOI 10.1006/expr.1997.4147
   KIMURA E, 1990, GENE, V91, P57, DOI 10.1016/0378-1119(90)90162-K
   KONATE L, 1999, T ROYAL SOC TROPI S1, V93
   Kyes S, 1997, AM J TROP MED HYG, V57, P205, DOI 10.4269/ajtmh.1997.57.205
   Lyon JA, 1997, MOL BIOCHEM PARASIT, V90, P223, DOI 10.1016/S0166-6851(97)00155-2
   MARCELO L, 1994, AM J TROP MED HYG, V51, P16, DOI 10.4269/ajtmh.1994.51.16
   Molineaux L, 1996, ANN TROP MED PARASIT, V90, P379, DOI 10.1080/00034983.1996.11813067
   NEI M, 1983, ANN HUM GENET, V47, P253, DOI 10.1111/j.1469-1809.1983.tb00993.x
   Sakihama N, 1999, GENE, V230, P47, DOI 10.1016/S0378-1119(99)00069-4
   SILVEIRA LA, 1999, INFECT IMMUN, V67, P5906
   Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7
   Tanabe K, 2000, GENE, V241, P325, DOI 10.1016/S0378-1119(99)00472-2
   TANABE K, 1987, J MOL BIOL, V195, P273, DOI 10.1016/0022-2836(87)90649-8
NR 30
TC 16
Z9 17
U1 0
U2 0
PU CARFAX PUBLISHING
PI BASINGSTOKE
PA RANKINE RD, BASINGSTOKE RG24 8PR, HANTS, ENGLAND
SN 0003-4983
J9 ANN TROP MED PARASIT
JI Ann. Trop. Med. Parasitol.
PD OCT
PY 2000
VL 94
IS 7
BP 675
EP 688
DI 10.1080/00034983.2000.11813591
PG 14
WC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
SC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
GA 382AW
UT WOS:000165797100002
PM 11144809
DA 2020-12-08
ER

PT J
AU da Silva, NS
   Viana, AB
   Cordeiro, JA
   Cavasini, CE
AF da Silva, NS
   Viana, AB
   Cordeiro, JA
   Cavasini, CE
TI American cutaneous leishmaniasis in the State of Acre, Brazil
SO REVISTA DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Leishmaniasis, mucocutaneous epidemiology health surveys; residence
   characteristics
AB Objective Present a statistical survey of American Cutaneous Leishmaniasis (ACL) in the State of Acre.
   Methods Data were obtained from the forms of the "Campaign against Leishmaniasis", from January 1992 to December 1997. Descriptive statistical analysis was applied.
   Results There were 2.557 registered cases. The highest prevalence was found at the microregion of Brasileia (231.8 cases/10,000 inhab.). The predominant clinical form was cutaneous (84.05%). The disease occurred mostly among males (71.02%). Half of the cases were among people with 24 years of age or younger Most cases were people with rural occupations. 83.97% of the cases were diagnosed by clinical examination. The longest period to seek medical treatment was registered in the mesoregion of Jurua Valley (10.37 months)
   Conclusion The high number of cases suggests that it might be necessary to study the psychosocial implications of the disease and identify factors contributing to the delay in treatment.
C1 Fac Med Sao Jose Rio Preto, Dept Doencas Infecciosas & Parasitarias, San Jose Rio Preto, SP, Brazil.
   Univ Fed Sao Carlos, BR-13560 Sao Carlos, SP, Brazil.
RP Cavasini, CE (corresponding author), Ave Faria Lima 5416, BR-15090000 San Jose Rio Preto, SP, Brazil.
EM natalss@hotmail.com
RI da Silva, Natal Santos/E-9579-2015
OI da Silva, Natal Santos/0000-0002-0856-1748
CR ARIAS IR, 1981, MEM I O CRUZ, V76, P279
   Costa J M, 1998, Rev Soc Bras Med Trop, V31, P279, DOI 10.1590/S0037-86821998000300005
   FALQUETO A, 1997, TRATADO INFECT, P1221
   *FUND IBGE, 1997, ANN EST ACR 1997
   GENARO O, 1997, PARASITOLOGIA HUMANA, P41
   HABIB F, 1983, SAUDE AMAZONIA SL, P37
   *I E CHAG, 1996, REL EQUINQ 1991 1995
   LACERDA MM, 1994, MEM I OSWALDO CRUZ, V89, P489, DOI 10.1590/S0074-02761994000300036
   Lainson R, 1997, TRATADO INFECT, P1495
   REY L, 1991, COMPLEXO LEISHMANIA, P193
   RODRIGUES EB, 1997, ESTATISTICA 1996
   Stolf Hamilton Ometto, 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P437, DOI 10.1590/S0036-46651993000500009
   TALHARI S, 1988, BRAS DERMATOL, V63, P433
   TEODORO U, 1993, REV SAUDE PUBL, V27, P242, DOI 10.1590/S0034-89101993000400003
   Zoia E N, 1996, Rev Bras Enferm, V49, P445
NR 15
TC 5
Z9 5
U1 0
U2 1
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD DEC
PY 1999
VL 33
IS 6
BP 554
EP 559
DI 10.1590/S0034-89101999000600006
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 284ED
UT WOS:000085317000006
PM 10689371
OA DOAJ Gold
DA 2020-12-08
ER

EF